<!DOCTYPE html><html lang="en"><head><title>Granza Bio: Cancer targeting attack particles | Y Combinator</title><meta name="csrf-param" content="authenticity_token" />
<meta name="csrf-token" content="i3jHOocClWmbcEdshuiF3jJkWywZmkfWrFq-clzVDE5WDOP8Vx1C_YXfjzG60wfYGSMWp6dkckUpLdShLIx2iQ" /><meta charset="utf-8" /><meta content="IE=edge;chrome=1" http-equiv="X-UA-Compatible" /><script nonce="/XsmmLq2go+LONmlUmYw+Q==">(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
})(window,document,'script','//www.google-analytics.com/analytics.js','ga');

ga('create', 'UA-51714649-1', 'auto');
ga('require', 'linkid', 'linkid.js');
ga('send', 'pageview');

(function(e,t){var n=e.amplitude||{_q:[],_iq:{}};var r=t.createElement("script")
;r.type="text/javascript"
;r.integrity="sha384-9jIJQlEp6cEk6foaEO/N5yzaJmQbTtugbpg9l8P/javk55WlPh7fJGR1vHhyDjON"
;r.crossOrigin="anonymous";r.async=true
;r.src="https://cdn.amplitude.com/libs/amplitude-8.4.0-min.gz.js"
;r.onload=function(){if(!e.amplitude.runQueuedFunctions){
console.log("[Amplitude] Error: could not load SDK")}}
;var i=t.getElementsByTagName("script")[0];i.parentNode.insertBefore(r,i)
;function s(e,t){e.prototype[t]=function(){
this._q.push([t].concat(Array.prototype.slice.call(arguments,0)));return this}}
var o=function(){this._q=[];return this}
;var a=["add","append","clearAll","prepend","set","setOnce","unset","preInsert","postInsert","remove"]
;for(var c=0;c<a.length;c++){s(o,a[c])}n.Identify=o;var u=function(){this._q=[]
;return this}
;var l=["setProductId","setQuantity","setPrice","setRevenueType","setEventProperties"]
;for(var p=0;p<l.length;p++){s(u,l[p])}n.Revenue=u
;var d=["init","logEvent","logRevenue","setUserId","setUserProperties","setOptOut","setVersionName","setDomain","setDeviceId","enableTracking","setGlobalUserProperties","identify","clearUserProperties","setGroup","logRevenueV2","regenerateDeviceId","groupIdentify","onInit","logEventWithTimestamp","logEventWithGroups","setSessionId","resetSessionId"]
;function v(e){function t(t){e[t]=function(){
e._q.push([t].concat(Array.prototype.slice.call(arguments,0)))}}
for(var n=0;n<d.length;n++){t(d[n])}}v(n);n.getInstance=function(e){
e=(!e||e.length===0?"$default_instance":e).toLowerCase()
;if(!Object.prototype.hasOwnProperty.call(n._iq,e)){n._iq[e]={_q:[]};v(n._iq[e])
}return n._iq[e]};e.amplitude=n})(window,document);
function isAmplitudeLoaded() {
  return !!window.amplitude.runQueuedFunctions
}

function parseUrl(url){
  var a = document.createElement('a');
  a.href = url;
  return {
    href: a.href,
    host: a.host || location.host,
    port: ('0' === a.port || '' === a.port) ? port(a.protocol) : a.port,
    hash: a.hash,
    hostname: a.hostname || location.hostname,
    pathname: a.pathname.charAt(0) != '/' ? '/' + a.pathname : a.pathname,
    protocol: !a.protocol || ':' == a.protocol ? location.protocol : a.protocol,
    search: a.search,
    query: a.search.slice(1)
  };
};

function canonical() {
  var tags = document.getElementsByTagName('link');
  for (var i = 0, tag; tag = tags[i]; i++) {
    if (tag.getAttribute('rel') === 'canonical') {
      return tag.getAttribute('href');
    }
  }
}

function canonicalPath() {
  var canon = canonical();
  if (!canon) return window.location.pathname;
  return parseUrl(canon).pathname;
}

function canonicalUrl(search) {
  var canon = canonical();
  if (canon) return canon.indexOf('?') !== -1 ? canon : canon + search;
  var url = window.location.href;
  var i = url.indexOf('#');
  return i === -1 ? url : url.slice(0, i);
}

amplitude.getInstance().init("dd1bb83142f9330da675b495ef578258", null, {includeReferrer: true, includeUtm: true, includeGclid: true});</script><meta content="summary_large_image" name="twitter:card" /><meta content="@ycombinator" name="twitter:site" /><meta content="https://bookface-images.s3.us-west-2.amazonaws.com/logos/5af6ba4d65c73cf6cdec05dbb069495ee36ae773.png?X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Credential=ASIAQC4NIECAOAZF5OPK%2F20240909%2Fus-west-2%2Fs3%2Faws4_request&amp;X-Amz-Date=20240909T063033Z&amp;X-Amz-Expires=3600&amp;X-Amz-Security-Token=IQoJb3JpZ2luX2VjEC4aCXVzLXdlc3QtMiJIMEYCIQC6PMB8F3tLhC1LgZi%2B%2BuOeMuT8xWaJocDVQsTVm4LDxwIhAKM7Yx2PZ5DVAO3UNlOv2lHhUDcbGWhd4soaoYdDcJLiKuUDCFcQABoMMDA2MjAxODExMDcyIgx%2BCbdALY3WKo2lEB4qwgN4r22%2B9P0f%2B2yravipsTqEUG%2FczMWdPaqQ5MFdNDA32rLIipLzoMJiRRUoj%2Bdfl4Zn5vB8W8WQLEvgQ%2BC2JS4%2FrneWy6SMdzaRspsy2RkqPY07knKxt6Ro9mX%2BAZDaX%2BCLuAWF5Ptdg6ySpHhcaBVUepAgFHD8Y5l8TOfix6ccA2nI%2BwaCT8eQd%2FvFBAYzYOHxz2T%2FBtrLM3vTIjIQpXhVA4wLkni%2F6JWKrtrgfKy1C0LU7%2FsOwyeTEHLgx%2F9iHZStsmzCacSDuuJ2VBpFzXIn%2BPgl1G%2FL3SwcOdVXRyU08TmpA4hs7om9GQ2zBpl2uIywqLr8Ns7vSm7ZU%2Fwyf237mDK4ELpXhpMcatweNujmgzUvuWS%2BTGESofv2EUXa6m5FvWNmgrW0dCgp6ibDuf%2Bs9SSc54k3%2BtYP710eskdjXZcgPG2joKfh3ruh8%2F7q7b%2Fk0ydfg%2FHlMG8kJ9zSPJ41HUP3%2FFRD1g715zSBXY9dQkvpT4oCjBNFlOxtkSpHdqhVJoTXwCjbltXuFhuri7V13CRzbS7ECUhTUY1%2B4FvSItFiH3BMIXarTh3N2LYmtTXJoRbInPJvNv%2Fv49sCcaZ3XxIwhpr6tgY6pAFaSnEZEhA%2FGoDn9kaSASqz%2FQjgwNLJzXfnuyR%2BwZzJHYeiYLQ9GIIEvSx84TlHHMkq3XbUgorF8009Pcr7hjT0qn14qSv%2FxSVb6%2FJA0WaxQF1rwSffJbqa8o7rH49tbvJyaapr8TTGmAlJL8Iexk3VmxxxBYaUmsJjUGunQmgonDUKV9X38d1tBQH%2Bf9GZclUO9nu0rka1V9UYLRMOBB1nD43ilA%3D%3D&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Signature=cfa41885082723861dcb4a6719ee0d54113e1730c49d82f609150989cce839d5" name="twitter:image" /><meta content="initial-scale=1, width=device-width, height=device-height" name="viewport" /><meta content="follow" name="robots" /><meta content="Granza Bio: Cancer targeting attack particles" name="title" /><meta content="Cancer targeting attack particles. Founded in 2023 by Ashwin Jainarayanan and Ashwin Nandakumar, Granza Bio has 2 employees based in San Francisco, CA, USA." name="description" /><meta content="https://bookface-images.s3.us-west-2.amazonaws.com/logos/5af6ba4d65c73cf6cdec05dbb069495ee36ae773.png?X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Credential=ASIAQC4NIECAOAZF5OPK%2F20240909%2Fus-west-2%2Fs3%2Faws4_request&amp;X-Amz-Date=20240909T063033Z&amp;X-Amz-Expires=3600&amp;X-Amz-Security-Token=IQoJb3JpZ2luX2VjEC4aCXVzLXdlc3QtMiJIMEYCIQC6PMB8F3tLhC1LgZi%2B%2BuOeMuT8xWaJocDVQsTVm4LDxwIhAKM7Yx2PZ5DVAO3UNlOv2lHhUDcbGWhd4soaoYdDcJLiKuUDCFcQABoMMDA2MjAxODExMDcyIgx%2BCbdALY3WKo2lEB4qwgN4r22%2B9P0f%2B2yravipsTqEUG%2FczMWdPaqQ5MFdNDA32rLIipLzoMJiRRUoj%2Bdfl4Zn5vB8W8WQLEvgQ%2BC2JS4%2FrneWy6SMdzaRspsy2RkqPY07knKxt6Ro9mX%2BAZDaX%2BCLuAWF5Ptdg6ySpHhcaBVUepAgFHD8Y5l8TOfix6ccA2nI%2BwaCT8eQd%2FvFBAYzYOHxz2T%2FBtrLM3vTIjIQpXhVA4wLkni%2F6JWKrtrgfKy1C0LU7%2FsOwyeTEHLgx%2F9iHZStsmzCacSDuuJ2VBpFzXIn%2BPgl1G%2FL3SwcOdVXRyU08TmpA4hs7om9GQ2zBpl2uIywqLr8Ns7vSm7ZU%2Fwyf237mDK4ELpXhpMcatweNujmgzUvuWS%2BTGESofv2EUXa6m5FvWNmgrW0dCgp6ibDuf%2Bs9SSc54k3%2BtYP710eskdjXZcgPG2joKfh3ruh8%2F7q7b%2Fk0ydfg%2FHlMG8kJ9zSPJ41HUP3%2FFRD1g715zSBXY9dQkvpT4oCjBNFlOxtkSpHdqhVJoTXwCjbltXuFhuri7V13CRzbS7ECUhTUY1%2B4FvSItFiH3BMIXarTh3N2LYmtTXJoRbInPJvNv%2Fv49sCcaZ3XxIwhpr6tgY6pAFaSnEZEhA%2FGoDn9kaSASqz%2FQjgwNLJzXfnuyR%2BwZzJHYeiYLQ9GIIEvSx84TlHHMkq3XbUgorF8009Pcr7hjT0qn14qSv%2FxSVb6%2FJA0WaxQF1rwSffJbqa8o7rH49tbvJyaapr8TTGmAlJL8Iexk3VmxxxBYaUmsJjUGunQmgonDUKV9X38d1tBQH%2Bf9GZclUO9nu0rka1V9UYLRMOBB1nD43ilA%3D%3D&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Signature=cfa41885082723861dcb4a6719ee0d54113e1730c49d82f609150989cce839d5" name="image" /><meta content="website" property="og:type" /><meta content="en_US" property="og:locale" /><meta content="Y Combinator" property="og:site_name" /><meta content="Granza Bio: Cancer targeting attack particles | Y Combinator" property="og:title" /><meta content="https://bookface-images.s3.us-west-2.amazonaws.com/logos/5af6ba4d65c73cf6cdec05dbb069495ee36ae773.png?X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Credential=ASIAQC4NIECAOAZF5OPK%2F20240909%2Fus-west-2%2Fs3%2Faws4_request&amp;X-Amz-Date=20240909T063033Z&amp;X-Amz-Expires=3600&amp;X-Amz-Security-Token=IQoJb3JpZ2luX2VjEC4aCXVzLXdlc3QtMiJIMEYCIQC6PMB8F3tLhC1LgZi%2B%2BuOeMuT8xWaJocDVQsTVm4LDxwIhAKM7Yx2PZ5DVAO3UNlOv2lHhUDcbGWhd4soaoYdDcJLiKuUDCFcQABoMMDA2MjAxODExMDcyIgx%2BCbdALY3WKo2lEB4qwgN4r22%2B9P0f%2B2yravipsTqEUG%2FczMWdPaqQ5MFdNDA32rLIipLzoMJiRRUoj%2Bdfl4Zn5vB8W8WQLEvgQ%2BC2JS4%2FrneWy6SMdzaRspsy2RkqPY07knKxt6Ro9mX%2BAZDaX%2BCLuAWF5Ptdg6ySpHhcaBVUepAgFHD8Y5l8TOfix6ccA2nI%2BwaCT8eQd%2FvFBAYzYOHxz2T%2FBtrLM3vTIjIQpXhVA4wLkni%2F6JWKrtrgfKy1C0LU7%2FsOwyeTEHLgx%2F9iHZStsmzCacSDuuJ2VBpFzXIn%2BPgl1G%2FL3SwcOdVXRyU08TmpA4hs7om9GQ2zBpl2uIywqLr8Ns7vSm7ZU%2Fwyf237mDK4ELpXhpMcatweNujmgzUvuWS%2BTGESofv2EUXa6m5FvWNmgrW0dCgp6ibDuf%2Bs9SSc54k3%2BtYP710eskdjXZcgPG2joKfh3ruh8%2F7q7b%2Fk0ydfg%2FHlMG8kJ9zSPJ41HUP3%2FFRD1g715zSBXY9dQkvpT4oCjBNFlOxtkSpHdqhVJoTXwCjbltXuFhuri7V13CRzbS7ECUhTUY1%2B4FvSItFiH3BMIXarTh3N2LYmtTXJoRbInPJvNv%2Fv49sCcaZ3XxIwhpr6tgY6pAFaSnEZEhA%2FGoDn9kaSASqz%2FQjgwNLJzXfnuyR%2BwZzJHYeiYLQ9GIIEvSx84TlHHMkq3XbUgorF8009Pcr7hjT0qn14qSv%2FxSVb6%2FJA0WaxQF1rwSffJbqa8o7rH49tbvJyaapr8TTGmAlJL8Iexk3VmxxxBYaUmsJjUGunQmgonDUKV9X38d1tBQH%2Bf9GZclUO9nu0rka1V9UYLRMOBB1nD43ilA%3D%3D&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Signature=cfa41885082723861dcb4a6719ee0d54113e1730c49d82f609150989cce839d5" property="og:image" /><meta content="https://bookface-images.s3.us-west-2.amazonaws.com/logos/5af6ba4d65c73cf6cdec05dbb069495ee36ae773.png?X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Credential=ASIAQC4NIECAOAZF5OPK%2F20240909%2Fus-west-2%2Fs3%2Faws4_request&amp;X-Amz-Date=20240909T063033Z&amp;X-Amz-Expires=3600&amp;X-Amz-Security-Token=IQoJb3JpZ2luX2VjEC4aCXVzLXdlc3QtMiJIMEYCIQC6PMB8F3tLhC1LgZi%2B%2BuOeMuT8xWaJocDVQsTVm4LDxwIhAKM7Yx2PZ5DVAO3UNlOv2lHhUDcbGWhd4soaoYdDcJLiKuUDCFcQABoMMDA2MjAxODExMDcyIgx%2BCbdALY3WKo2lEB4qwgN4r22%2B9P0f%2B2yravipsTqEUG%2FczMWdPaqQ5MFdNDA32rLIipLzoMJiRRUoj%2Bdfl4Zn5vB8W8WQLEvgQ%2BC2JS4%2FrneWy6SMdzaRspsy2RkqPY07knKxt6Ro9mX%2BAZDaX%2BCLuAWF5Ptdg6ySpHhcaBVUepAgFHD8Y5l8TOfix6ccA2nI%2BwaCT8eQd%2FvFBAYzYOHxz2T%2FBtrLM3vTIjIQpXhVA4wLkni%2F6JWKrtrgfKy1C0LU7%2FsOwyeTEHLgx%2F9iHZStsmzCacSDuuJ2VBpFzXIn%2BPgl1G%2FL3SwcOdVXRyU08TmpA4hs7om9GQ2zBpl2uIywqLr8Ns7vSm7ZU%2Fwyf237mDK4ELpXhpMcatweNujmgzUvuWS%2BTGESofv2EUXa6m5FvWNmgrW0dCgp6ibDuf%2Bs9SSc54k3%2BtYP710eskdjXZcgPG2joKfh3ruh8%2F7q7b%2Fk0ydfg%2FHlMG8kJ9zSPJ41HUP3%2FFRD1g715zSBXY9dQkvpT4oCjBNFlOxtkSpHdqhVJoTXwCjbltXuFhuri7V13CRzbS7ECUhTUY1%2B4FvSItFiH3BMIXarTh3N2LYmtTXJoRbInPJvNv%2Fv49sCcaZ3XxIwhpr6tgY6pAFaSnEZEhA%2FGoDn9kaSASqz%2FQjgwNLJzXfnuyR%2BwZzJHYeiYLQ9GIIEvSx84TlHHMkq3XbUgorF8009Pcr7hjT0qn14qSv%2FxSVb6%2FJA0WaxQF1rwSffJbqa8o7rH49tbvJyaapr8TTGmAlJL8Iexk3VmxxxBYaUmsJjUGunQmgonDUKV9X38d1tBQH%2Bf9GZclUO9nu0rka1V9UYLRMOBB1nD43ilA%3D%3D&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Signature=cfa41885082723861dcb4a6719ee0d54113e1730c49d82f609150989cce839d5" property="og:image:url" /><meta content="https://bookface-images.s3.us-west-2.amazonaws.com/logos/5af6ba4d65c73cf6cdec05dbb069495ee36ae773.png?X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Credential=ASIAQC4NIECAOAZF5OPK%2F20240909%2Fus-west-2%2Fs3%2Faws4_request&amp;X-Amz-Date=20240909T063033Z&amp;X-Amz-Expires=3600&amp;X-Amz-Security-Token=IQoJb3JpZ2luX2VjEC4aCXVzLXdlc3QtMiJIMEYCIQC6PMB8F3tLhC1LgZi%2B%2BuOeMuT8xWaJocDVQsTVm4LDxwIhAKM7Yx2PZ5DVAO3UNlOv2lHhUDcbGWhd4soaoYdDcJLiKuUDCFcQABoMMDA2MjAxODExMDcyIgx%2BCbdALY3WKo2lEB4qwgN4r22%2B9P0f%2B2yravipsTqEUG%2FczMWdPaqQ5MFdNDA32rLIipLzoMJiRRUoj%2Bdfl4Zn5vB8W8WQLEvgQ%2BC2JS4%2FrneWy6SMdzaRspsy2RkqPY07knKxt6Ro9mX%2BAZDaX%2BCLuAWF5Ptdg6ySpHhcaBVUepAgFHD8Y5l8TOfix6ccA2nI%2BwaCT8eQd%2FvFBAYzYOHxz2T%2FBtrLM3vTIjIQpXhVA4wLkni%2F6JWKrtrgfKy1C0LU7%2FsOwyeTEHLgx%2F9iHZStsmzCacSDuuJ2VBpFzXIn%2BPgl1G%2FL3SwcOdVXRyU08TmpA4hs7om9GQ2zBpl2uIywqLr8Ns7vSm7ZU%2Fwyf237mDK4ELpXhpMcatweNujmgzUvuWS%2BTGESofv2EUXa6m5FvWNmgrW0dCgp6ibDuf%2Bs9SSc54k3%2BtYP710eskdjXZcgPG2joKfh3ruh8%2F7q7b%2Fk0ydfg%2FHlMG8kJ9zSPJ41HUP3%2FFRD1g715zSBXY9dQkvpT4oCjBNFlOxtkSpHdqhVJoTXwCjbltXuFhuri7V13CRzbS7ECUhTUY1%2B4FvSItFiH3BMIXarTh3N2LYmtTXJoRbInPJvNv%2Fv49sCcaZ3XxIwhpr6tgY6pAFaSnEZEhA%2FGoDn9kaSASqz%2FQjgwNLJzXfnuyR%2BwZzJHYeiYLQ9GIIEvSx84TlHHMkq3XbUgorF8009Pcr7hjT0qn14qSv%2FxSVb6%2FJA0WaxQF1rwSffJbqa8o7rH49tbvJyaapr8TTGmAlJL8Iexk3VmxxxBYaUmsJjUGunQmgonDUKV9X38d1tBQH%2Bf9GZclUO9nu0rka1V9UYLRMOBB1nD43ilA%3D%3D&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Signature=cfa41885082723861dcb4a6719ee0d54113e1730c49d82f609150989cce839d5" property="og:image:secure_url" /><meta content="https://www.ycombinator.com/companies/granza-bio" property="og:url" /><meta content="Cancer targeting attack particles. Founded in 2023 by Ashwin Jainarayanan and Ashwin Nandakumar, Granza Bio has 2 employees based in San Francisco, CA, USA." property="og:description" /><meta content="23YLYcfP-tmEiWdemh9h6Wi6DIxisMtUtcowUJBSvH0" property="google-site-verification" /><link href="https://bookface-static.ycombinator.com/assets/ycdc/favicon-c8a914eeeba9fe6f7a863b35608b55aeedd7c1ff409c97b9ecb96b7a6c278d70.ico" rel="icon" type="image/x-icon" /><link href="https://bookface-static.ycombinator.com/assets/ycdc/favicon-c8a914eeeba9fe6f7a863b35608b55aeedd7c1ff409c97b9ecb96b7a6c278d70.ico" rel="shortcut icon" type="image/x-icon" /><link href="https://www.ycombinator.com/blog/feed" rel="alternate" type="application/rss+xml" /><link href="https://plus.google.com/113116812547402050884" rel="publisher" /><link href="https://www.ycombinator.com/companies/granza-bio" rel="canonical" /><script src="https://maps.googleapis.com/maps/api/js?key=AIzaSyC0BuJ43Ncbmuro17vVxWJWrOzzAPZ0rQE&amp;libraries=places&amp;language=en"></script><script nonce="/XsmmLq2go+LONmlUmYw+Q==">window.process = {
  cwd: () => "/",
  env: {},
};
window.AlgoliaOpts = {"indices_not_set":true};
window.RAILS_ENV = 'production';</script><script src="https://bookface-static.ycombinator.com/vite/assets/ycdc-styles-tlE2zkBQ.js" crossorigin="anonymous" type="module"></script>
<script src="https://bookface-static.ycombinator.com/vite/assets/inertia-ycdc-DjlRYsUR.js" crossorigin="anonymous" type="module"></script><link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-CHBdaeRh.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/component_registry-0yPM0QIr.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/core.browser.esm-E-JRWgR0.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/_commonjsHelpers-BosuxZz1.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-C1XNiT28.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/mande-58egg929.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index.esm-CU-Y7ilA.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/cjs-CZcpZRFy.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/classNames-6G_CiVqM.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/___vite-browser-external_commonjs-proxy-DRaEfepn.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/unleash-react-CCI9exSZ.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-VBeXkHpw.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/extends-B6xKY8K9.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/objectWithoutPropertiesLoose-1QL-frMM.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/tiny-invariant-CopsF_GD.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/setPrototypeOf-DgZC2w_0.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-Dk74W0Oi.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-8JwjhRSi.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/hoist-non-react-statics.cjs-8LEXEXzt.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-C2BwWiaW.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/EditDeal-hfc6heF_.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/authorizedFetch-BqGRWKIE.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/MarkdownEditor-CQwrfIj7.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/ResizeObserver.es-Vp3fAUIx.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/renderMarkdown-CZPcVa8U.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/_commonjs-dynamic-modules-TDtrdbi3.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/lodash-VTYhv_Tp.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/QueryStringUtils-D-jSyckr.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/_baseIteratee-uk0t9C_N.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/_getPrototype-_wpbdt_m.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/util-DkO_ZghF.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/tslib.es6-DvdiYjtx.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/debounce-H0c2raoX.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index.es-CXbMkK9L.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-C25f_UcB.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/TipTapEditor-C6RRrqC3.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-DBtS7Iv-.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/react-datepicker-B2sVt98_.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/module-LCTozozC.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/algoliaClient-CwRpZzXj.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/algoliasearch-C9qOpiFN.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/CopyToClipboard-BeWYCol_.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/YCComponentContext-BNH0XcCx.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/v4-8I8R7izr.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/Button-B3eFcKVS.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-ZqNk8tGT.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/cn-DK8rbcAd.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/moment-BPvxSG8c.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/orderBy-DlgfTM6F.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/_baseOrderBy-vcu7XgHE.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/Dialog-NhSKM8IM.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-CP-vb5ff.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-o57hoRgn.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-DcVctD5_.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-51xgH-_N.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-GT4tn-Tq.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-Dor_DwLN.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/react-lifecycles-compat.es-BQsrzbwh.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/Popover-BEVmvAq9.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/toConsumableArray-CcSY77m1.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/createClass-CKzb60xw.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/defineProperty-BDQDPHu9.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/typeof-QjJsDpFa.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/assertThisInitialized-B9jnkVVz.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-BRFn9q4h.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-BNaxIM6b.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-CmiZR98m.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/classCallCheck-BEHuYeFB.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/Pills-B018DkvK.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-0cON0Ju7.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/styles.module-CVNVABNB.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/InfiniteScroll-UNiBcbGE.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/amplitude-PL9gHsr1.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/Textarea-BtMHCIvW.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/Label-CnM77npc.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/Input-DKWexRhN.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/YCAlerts-BLzCF5Gk.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-BlH2E8pn.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/isEmail-DRwgp1RT.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-BMIzfmjl.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-D0PE8nRZ.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/preload-helper-sHZF7d9t.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/memoize-one.esm-DhmFm5Lm.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-BuI7ZZLZ.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/Avatar-CfFjLt3y.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/Input-DVaj1xhJ.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-COHti_Ua.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/Select-OFH5U2so.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/AutosizeInput-up3c_Whj.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/useMutation-Bvr0Xsp2.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/Toast-D_N_amBA.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/TimeAgo-CMSriLlY.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-BEM2NJH4.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-DCWtcB_f.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/useIsomorphicLayoutEffect-CGYpRj0Z.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/immutable.es-Bg0TTMEW.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-BXaXAVmu.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-DW0OAk5Y.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-Cp1tdalh.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/algoliasearch-lite.umd-DCwbrWop.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/he-Bqiny3Uv.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/numeral-CAB4neXj.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-BKYPd4H-.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/Helmet-kyA0jcZq.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-DC8rhvxf.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/Portal-DyZYRPX4.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/removeClass-DDeOzAA6.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/CloseButton-DCBUF8Vc.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/react-select.esm-DlTOzZ4K.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/stateManager-845a3300.esm-BFPC6-LP.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-DUVfEdqN.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/DoubleSliderFacet-BrrWkaf9.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/DropdownMenu-BcuSuLn7.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-BPKZ5nYq.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/circle-BkgAFBmM.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/BookfacePage-qQkRhd9x.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/Button-BoZhtHVv.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/Select-zZPAmWHt.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/react-select.esm-D9-9r9oo.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/index-byHH18by.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/_isIterateeCall-BRUwO0R_.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/CompanyListItemContent-ClkZvQ0H.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/SharedDirectory-ZSm402Nx.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/ThrottledInfiniteScroll-gxPPSMG5.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/throttle-DAAITbsi.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/InlineLoader-y-Jhgilx.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/hub-CJ_O3EZM.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/CompanySizeChoices-h5iPbGvR.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/ycombinator-logo-BFMOMBng.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/Card-CEGHXGBx.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/useFetch-Dw2OXQCl.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/Tabs-19L4Ixx3.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/withRailsContext-BdQXl7Yy.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/Panel-wyqOD6Sk.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/Table-5H66V4ci.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/Alert-BoeJpdLG.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/jquery-rTXOsbo7.js" as="script" crossorigin="anonymous">
<link rel="modulepreload" href="https://bookface-static.ycombinator.com/vite/assets/utils-BKrstCcm.js" as="script" crossorigin="anonymous"><link rel="stylesheet" href="https://bookface-static.ycombinator.com/vite/assets/ycdc-styles-BIwlwiQc.css" media="screen" />
<link rel="stylesheet" href="https://bookface-static.ycombinator.com/vite/assets/Launches-DobiAliQ.css" media="screen" />
<link rel="stylesheet" href="https://bookface-static.ycombinator.com/vite/assets/LaunchesFormPage-CiIa-AM9.css" media="screen" />
<link rel="stylesheet" href="https://bookface-static.ycombinator.com/vite/assets/LaunchesIndexPage-CEA8DHsA.css" media="screen" />
<link rel="stylesheet" href="https://bookface-static.ycombinator.com/vite/assets/LaunchesPage-t3FjDsRN.css" media="screen" />
<link rel="stylesheet" href="https://bookface-static.ycombinator.com/vite/assets/LaunchesShowPage-CDqq54e1.css" media="screen" />
<link rel="stylesheet" href="https://bookface-static.ycombinator.com/vite/assets/WhyPage-CwMB6kJ9.css" media="screen" />
<link rel="stylesheet" href="https://bookface-static.ycombinator.com/vite/assets/Breadcrumb-Q8jBgsK4.css" media="screen" />
<link rel="stylesheet" href="https://bookface-static.ycombinator.com/vite/assets/nouislider-CENb39KG.css" media="screen" />
<link rel="stylesheet" href="https://bookface-static.ycombinator.com/vite/assets/editor-qXBN2xh0.css" media="screen" />
<link rel="stylesheet" href="https://bookface-static.ycombinator.com/vite/assets/history-Cpfv0XKS.css" media="screen" />
<link rel="stylesheet" href="https://bookface-static.ycombinator.com/vite/assets/Dropdown-n5E_oJGb.css" media="screen" />
<link rel="stylesheet" href="https://bookface-static.ycombinator.com/vite/assets/tooltip-CwOxJ-O4.css" media="screen" />
<link rel="stylesheet" href="https://bookface-static.ycombinator.com/vite/assets/index-BVtZ5GXq.css" media="screen" />
<link rel="stylesheet" href="https://bookface-static.ycombinator.com/vite/assets/index-CfeY1va0.css" media="screen" />
<link rel="stylesheet" href="https://bookface-static.ycombinator.com/vite/assets/EditDeal-lkQ199B3.css" media="screen" />
<link rel="stylesheet" href="https://bookface-static.ycombinator.com/vite/assets/TipTapEditor-BS9qeBN-.css" media="screen" />
<link rel="stylesheet" href="https://bookface-static.ycombinator.com/vite/assets/react-datepicker-uzamEK4H.css" media="screen" />
<link rel="stylesheet" href="https://bookface-static.ycombinator.com/vite/assets/styles-BwufUiD5.css" media="screen" />
<link rel="stylesheet" href="https://bookface-static.ycombinator.com/vite/assets/YCAlerts-DCjzjmoU.css" media="screen" />
<link rel="stylesheet" href="https://bookface-static.ycombinator.com/vite/assets/DoubleSliderFacet-BAVDBqCS.css" media="screen" />
<link rel="stylesheet" href="https://bookface-static.ycombinator.com/vite/assets/Panel-BuXIi9xK.css" media="screen" /><script src="https://bookface-static.ycombinator.com/assets/blog-f79eba0d96062651c77f46dc87a7ec3eb6918939795b19098f6ec7502b7ddf8b.js" defer="defer"></script></head><body class="retro ycdc2 companies show"><div id="ycdc_new/pages/Companies/ShowPage-react-component-f90b9472-a670-467c-971e-cffb7ca4cb91" data-page="{&quot;component&quot;:&quot;ycdc_new/pages/Companies/ShowPage&quot;,&quot;props&quot;:{&quot;currentUser&quot;:null,&quot;company&quot;:{&quot;id&quot;:29485,&quot;slug&quot;:&quot;granza-bio&quot;,&quot;name&quot;:&quot;Granza Bio&quot;,&quot;batch_name&quot;:&quot;W24&quot;,&quot;small_logo_url&quot;:&quot;https://bookface-images.s3.amazonaws.com/small_logos/d4fd3a0da81bcc20531e81fb90c199f5f31bc368.png&quot;,&quot;one_liner&quot;:&quot;Cancer targeting attack particles&quot;,&quot;website&quot;:&quot;https://www.granzabio.com/&quot;,&quot;long_description&quot;:&quot;Granza Bio is developing cancer therapeutics modelled from our bodyâ€™s own immune system. Our therapeutics termed â€œattack particlesâ€ are engineered to specifically target only cancer cells, preventing any unwanted toxicity and adverse side effects. \r\n\r\nOur attack particles have shown cancer-killing efficacy in brain (glioblastoma), ovarian, lung, and skin cancers. Our platform can also be deployed to target a great range of diseases including autoimmune diseases and infections.\r\n\r\nInterested to know more? Get in touch founders@granzabio.com!&quot;,&quot;tags&quot;:[&quot;synthetic-biology&quot;,&quot;biotech&quot;,&quot;healthcare&quot;,&quot;therapeutics&quot;,&quot;oncology&quot;],&quot;ycdc_status&quot;:&quot;Active&quot;,&quot;logo_url&quot;:&quot;https://bookface-images.s3.us-west-2.amazonaws.com/logos/5af6ba4d65c73cf6cdec05dbb069495ee36ae773.png?X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Credential=ASIAQC4NIECAOAZF5OPK%2F20240909%2Fus-west-2%2Fs3%2Faws4_request&amp;X-Amz-Date=20240909T063033Z&amp;X-Amz-Expires=3600&amp;X-Amz-Security-Token=IQoJb3JpZ2luX2VjEC4aCXVzLXdlc3QtMiJIMEYCIQC6PMB8F3tLhC1LgZi%2B%2BuOeMuT8xWaJocDVQsTVm4LDxwIhAKM7Yx2PZ5DVAO3UNlOv2lHhUDcbGWhd4soaoYdDcJLiKuUDCFcQABoMMDA2MjAxODExMDcyIgx%2BCbdALY3WKo2lEB4qwgN4r22%2B9P0f%2B2yravipsTqEUG%2FczMWdPaqQ5MFdNDA32rLIipLzoMJiRRUoj%2Bdfl4Zn5vB8W8WQLEvgQ%2BC2JS4%2FrneWy6SMdzaRspsy2RkqPY07knKxt6Ro9mX%2BAZDaX%2BCLuAWF5Ptdg6ySpHhcaBVUepAgFHD8Y5l8TOfix6ccA2nI%2BwaCT8eQd%2FvFBAYzYOHxz2T%2FBtrLM3vTIjIQpXhVA4wLkni%2F6JWKrtrgfKy1C0LU7%2FsOwyeTEHLgx%2F9iHZStsmzCacSDuuJ2VBpFzXIn%2BPgl1G%2FL3SwcOdVXRyU08TmpA4hs7om9GQ2zBpl2uIywqLr8Ns7vSm7ZU%2Fwyf237mDK4ELpXhpMcatweNujmgzUvuWS%2BTGESofv2EUXa6m5FvWNmgrW0dCgp6ibDuf%2Bs9SSc54k3%2BtYP710eskdjXZcgPG2joKfh3ruh8%2F7q7b%2Fk0ydfg%2FHlMG8kJ9zSPJ41HUP3%2FFRD1g715zSBXY9dQkvpT4oCjBNFlOxtkSpHdqhVJoTXwCjbltXuFhuri7V13CRzbS7ECUhTUY1%2B4FvSItFiH3BMIXarTh3N2LYmtTXJoRbInPJvNv%2Fv49sCcaZ3XxIwhpr6tgY6pAFaSnEZEhA%2FGoDn9kaSASqz%2FQjgwNLJzXfnuyR%2BwZzJHYeiYLQ9GIIEvSx84TlHHMkq3XbUgorF8009Pcr7hjT0qn14qSv%2FxSVb6%2FJA0WaxQF1rwSffJbqa8o7rH49tbvJyaapr8TTGmAlJL8Iexk3VmxxxBYaUmsJjUGunQmgonDUKV9X38d1tBQH%2Bf9GZclUO9nu0rka1V9UYLRMOBB1nD43ilA%3D%3D&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Signature=cfa41885082723861dcb4a6719ee0d54113e1730c49d82f609150989cce839d5&quot;,&quot;year_founded&quot;:2023,&quot;team_size&quot;:2,&quot;location&quot;:&quot;San Francisco&quot;,&quot;city&quot;:&quot;San Francisco&quot;,&quot;city_tag&quot;:&quot;san-francisco-bay-area&quot;,&quot;country&quot;:&quot;US&quot;,&quot;linkedin_url&quot;:&quot;https://www.linkedin.com/company/101140973/&quot;,&quot;twitter_url&quot;:&quot;https://twitter.com/GranzaBio&quot;,&quot;fb_url&quot;:&quot;&quot;,&quot;cb_url&quot;:&quot;&quot;,&quot;github_url&quot;:&quot;&quot;,&quot;free_response_question_answers&quot;:[{&quot;id&quot;:&quot;1&quot;,&quot;answer&quot;:&quot;&quot;,&quot;question&quot;:&quot;How did your company get started? (i.e., How did the founders meet? How did you come up with the idea? How did you decide to be a founder?)&quot;},{&quot;id&quot;:&quot;2&quot;,&quot;answer&quot;:&quot;&quot;,&quot;question&quot;:&quot;How did you decide to apply to Y Combinator? What was your experience applying, going through the batch, and fundraising at demo day?&quot;},{&quot;id&quot;:&quot;3&quot;,&quot;answer&quot;:&quot;&quot;,&quot;question&quot;:&quot;How have you kept in touch with the YC community and continued to use YC resources &amp; programs since the batch ended?&quot;},{&quot;id&quot;:&quot;4&quot;,&quot;answer&quot;:&quot;&quot;,&quot;question&quot;:&quot;What&#x27;s the history of your company from getting started until the present day? What were the big inflection points?&quot;},{&quot;id&quot;:&quot;5&quot;,&quot;answer&quot;:&quot;&quot;,&quot;question&quot;:&quot;What is the core problem you are solving? Why is this a big problem? What made you decide to work on it?&quot;},{&quot;id&quot;:&quot;6&quot;,&quot;answer&quot;:&quot;&quot;,&quot;question&quot;:&quot;What is your long-term vision? If you truly succeed, what will be different about the world?&quot;}],&quot;dday_video_url&quot;:null,&quot;dday_presenter_id&quot;:1718918,&quot;app_video_url&quot;:null,&quot;app_answers&quot;:[],&quot;ycdc_company_url&quot;:&quot;/companies/granza-bio&quot;,&quot;company_photos&quot;:[{&quot;id&quot;:510,&quot;url&quot;:&quot;https://bookface-images.s3.us-west-2.amazonaws.com/attachments/951f3c1e19296f2e20fadafd3714fde2998a701f.png?X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Credential=ASIAQC4NIECAOAZF5OPK%2F20240909%2Fus-west-2%2Fs3%2Faws4_request&amp;X-Amz-Date=20240909T063033Z&amp;X-Amz-Expires=3600&amp;X-Amz-Security-Token=IQoJb3JpZ2luX2VjEC4aCXVzLXdlc3QtMiJIMEYCIQC6PMB8F3tLhC1LgZi%2B%2BuOeMuT8xWaJocDVQsTVm4LDxwIhAKM7Yx2PZ5DVAO3UNlOv2lHhUDcbGWhd4soaoYdDcJLiKuUDCFcQABoMMDA2MjAxODExMDcyIgx%2BCbdALY3WKo2lEB4qwgN4r22%2B9P0f%2B2yravipsTqEUG%2FczMWdPaqQ5MFdNDA32rLIipLzoMJiRRUoj%2Bdfl4Zn5vB8W8WQLEvgQ%2BC2JS4%2FrneWy6SMdzaRspsy2RkqPY07knKxt6Ro9mX%2BAZDaX%2BCLuAWF5Ptdg6ySpHhcaBVUepAgFHD8Y5l8TOfix6ccA2nI%2BwaCT8eQd%2FvFBAYzYOHxz2T%2FBtrLM3vTIjIQpXhVA4wLkni%2F6JWKrtrgfKy1C0LU7%2FsOwyeTEHLgx%2F9iHZStsmzCacSDuuJ2VBpFzXIn%2BPgl1G%2FL3SwcOdVXRyU08TmpA4hs7om9GQ2zBpl2uIywqLr8Ns7vSm7ZU%2Fwyf237mDK4ELpXhpMcatweNujmgzUvuWS%2BTGESofv2EUXa6m5FvWNmgrW0dCgp6ibDuf%2Bs9SSc54k3%2BtYP710eskdjXZcgPG2joKfh3ruh8%2F7q7b%2Fk0ydfg%2FHlMG8kJ9zSPJ41HUP3%2FFRD1g715zSBXY9dQkvpT4oCjBNFlOxtkSpHdqhVJoTXwCjbltXuFhuri7V13CRzbS7ECUhTUY1%2B4FvSItFiH3BMIXarTh3N2LYmtTXJoRbInPJvNv%2Fv49sCcaZ3XxIwhpr6tgY6pAFaSnEZEhA%2FGoDn9kaSASqz%2FQjgwNLJzXfnuyR%2BwZzJHYeiYLQ9GIIEvSx84TlHHMkq3XbUgorF8009Pcr7hjT0qn14qSv%2FxSVb6%2FJA0WaxQF1rwSffJbqa8o7rH49tbvJyaapr8TTGmAlJL8Iexk3VmxxxBYaUmsJjUGunQmgonDUKV9X38d1tBQH%2Bf9GZclUO9nu0rka1V9UYLRMOBB1nD43ilA%3D%3D&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Signature=a3487f8863ad7ec76bff2a2947e4b74202a249035c9aa7aa44c045904e5a0c01&quot;,&quot;photo_type&quot;:&quot;sign&quot;}],&quot;primary_group_partner&quot;:{&quot;id&quot;:455078,&quot;full_name&quot;:&quot;Surbhi Sarna&quot;,&quot;url&quot;:&quot;https://www.ycombinator.com/people/surbhi-sarna&quot;},&quot;founders&quot;:[{&quot;user_id&quot;:1718918,&quot;is_active&quot;:true,&quot;founder_bio&quot;:&quot;Ashwin completed his PhD (DPhil) in Oncology at the University of Oxford. After completing his PhD, he began working as a Cancer Research UK post-doctoral researcher at Oxford University and also at the Institute of Cancer Research (ICR), London. He also brings experience setting up oncology clinical trials and working in oncology start-ups. &quot;,&quot;full_name&quot;:&quot;Ashwin Nandakumar&quot;,&quot;title&quot;:null,&quot;avatar_thumb_url&quot;:&quot;https://bookface-images.s3.us-west-2.amazonaws.com/avatars/abf1515406e6713ee0ab505431bf72dd815baad6.jpg?X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Credential=ASIAQC4NIECAOAZF5OPK%2F20240909%2Fus-west-2%2Fs3%2Faws4_request&amp;X-Amz-Date=20240909T063033Z&amp;X-Amz-Expires=3600&amp;X-Amz-Security-Token=IQoJb3JpZ2luX2VjEC4aCXVzLXdlc3QtMiJIMEYCIQC6PMB8F3tLhC1LgZi%2B%2BuOeMuT8xWaJocDVQsTVm4LDxwIhAKM7Yx2PZ5DVAO3UNlOv2lHhUDcbGWhd4soaoYdDcJLiKuUDCFcQABoMMDA2MjAxODExMDcyIgx%2BCbdALY3WKo2lEB4qwgN4r22%2B9P0f%2B2yravipsTqEUG%2FczMWdPaqQ5MFdNDA32rLIipLzoMJiRRUoj%2Bdfl4Zn5vB8W8WQLEvgQ%2BC2JS4%2FrneWy6SMdzaRspsy2RkqPY07knKxt6Ro9mX%2BAZDaX%2BCLuAWF5Ptdg6ySpHhcaBVUepAgFHD8Y5l8TOfix6ccA2nI%2BwaCT8eQd%2FvFBAYzYOHxz2T%2FBtrLM3vTIjIQpXhVA4wLkni%2F6JWKrtrgfKy1C0LU7%2FsOwyeTEHLgx%2F9iHZStsmzCacSDuuJ2VBpFzXIn%2BPgl1G%2FL3SwcOdVXRyU08TmpA4hs7om9GQ2zBpl2uIywqLr8Ns7vSm7ZU%2Fwyf237mDK4ELpXhpMcatweNujmgzUvuWS%2BTGESofv2EUXa6m5FvWNmgrW0dCgp6ibDuf%2Bs9SSc54k3%2BtYP710eskdjXZcgPG2joKfh3ruh8%2F7q7b%2Fk0ydfg%2FHlMG8kJ9zSPJ41HUP3%2FFRD1g715zSBXY9dQkvpT4oCjBNFlOxtkSpHdqhVJoTXwCjbltXuFhuri7V13CRzbS7ECUhTUY1%2B4FvSItFiH3BMIXarTh3N2LYmtTXJoRbInPJvNv%2Fv49sCcaZ3XxIwhpr6tgY6pAFaSnEZEhA%2FGoDn9kaSASqz%2FQjgwNLJzXfnuyR%2BwZzJHYeiYLQ9GIIEvSx84TlHHMkq3XbUgorF8009Pcr7hjT0qn14qSv%2FxSVb6%2FJA0WaxQF1rwSffJbqa8o7rH49tbvJyaapr8TTGmAlJL8Iexk3VmxxxBYaUmsJjUGunQmgonDUKV9X38d1tBQH%2Bf9GZclUO9nu0rka1V9UYLRMOBB1nD43ilA%3D%3D&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Signature=f3a43e9142adfc8820edf5aa7ae76172e1b832e12c8327df06a63f0743b336da&quot;,&quot;twitter_url&quot;:&quot;https://twitter.com/Menon_Ashwin&quot;,&quot;linkedin_url&quot;:&quot;https://linkedin.com/in/ashwin-nandakumar-menon&quot;,&quot;has_email&quot;:true,&quot;latest_yc_company&quot;:{&quot;name&quot;:&quot;Granza Bio&quot;,&quot;href&quot;:&quot;/companies/granza-bio&quot;}},{&quot;user_id&quot;:1720525,&quot;is_active&quot;:true,&quot;founder_bio&quot;:&quot;Granza Bio, DPhil (PhD) in Interdisciplinary Bioscience - University of Oxford\n\n&quot;,&quot;full_name&quot;:&quot;Ashwin Jainarayanan&quot;,&quot;title&quot;:null,&quot;avatar_thumb_url&quot;:&quot;https://bookface-images.s3.us-west-2.amazonaws.com/avatars/d8cf072b7b583aa501ae03f0113abf686b2e0b73.jpg?X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Credential=ASIAQC4NIECAOAZF5OPK%2F20240909%2Fus-west-2%2Fs3%2Faws4_request&amp;X-Amz-Date=20240909T063033Z&amp;X-Amz-Expires=3600&amp;X-Amz-Security-Token=IQoJb3JpZ2luX2VjEC4aCXVzLXdlc3QtMiJIMEYCIQC6PMB8F3tLhC1LgZi%2B%2BuOeMuT8xWaJocDVQsTVm4LDxwIhAKM7Yx2PZ5DVAO3UNlOv2lHhUDcbGWhd4soaoYdDcJLiKuUDCFcQABoMMDA2MjAxODExMDcyIgx%2BCbdALY3WKo2lEB4qwgN4r22%2B9P0f%2B2yravipsTqEUG%2FczMWdPaqQ5MFdNDA32rLIipLzoMJiRRUoj%2Bdfl4Zn5vB8W8WQLEvgQ%2BC2JS4%2FrneWy6SMdzaRspsy2RkqPY07knKxt6Ro9mX%2BAZDaX%2BCLuAWF5Ptdg6ySpHhcaBVUepAgFHD8Y5l8TOfix6ccA2nI%2BwaCT8eQd%2FvFBAYzYOHxz2T%2FBtrLM3vTIjIQpXhVA4wLkni%2F6JWKrtrgfKy1C0LU7%2FsOwyeTEHLgx%2F9iHZStsmzCacSDuuJ2VBpFzXIn%2BPgl1G%2FL3SwcOdVXRyU08TmpA4hs7om9GQ2zBpl2uIywqLr8Ns7vSm7ZU%2Fwyf237mDK4ELpXhpMcatweNujmgzUvuWS%2BTGESofv2EUXa6m5FvWNmgrW0dCgp6ibDuf%2Bs9SSc54k3%2BtYP710eskdjXZcgPG2joKfh3ruh8%2F7q7b%2Fk0ydfg%2FHlMG8kJ9zSPJ41HUP3%2FFRD1g715zSBXY9dQkvpT4oCjBNFlOxtkSpHdqhVJoTXwCjbltXuFhuri7V13CRzbS7ECUhTUY1%2B4FvSItFiH3BMIXarTh3N2LYmtTXJoRbInPJvNv%2Fv49sCcaZ3XxIwhpr6tgY6pAFaSnEZEhA%2FGoDn9kaSASqz%2FQjgwNLJzXfnuyR%2BwZzJHYeiYLQ9GIIEvSx84TlHHMkq3XbUgorF8009Pcr7hjT0qn14qSv%2FxSVb6%2FJA0WaxQF1rwSffJbqa8o7rH49tbvJyaapr8TTGmAlJL8Iexk3VmxxxBYaUmsJjUGunQmgonDUKV9X38d1tBQH%2Bf9GZclUO9nu0rka1V9UYLRMOBB1nD43ilA%3D%3D&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Signature=29b24a3a37f185d61e2232b2a88439dad0bbbbc0749fa32653802a4a19c73f31&quot;,&quot;twitter_url&quot;:&quot;&quot;,&quot;linkedin_url&quot;:&quot;https://linkedin.com/in/jainarayananak&quot;,&quot;has_email&quot;:true,&quot;latest_yc_company&quot;:{&quot;name&quot;:&quot;Granza Bio&quot;,&quot;href&quot;:&quot;/companies/granza-bio&quot;}}]},&quot;jobPostings&quot;:[],&quot;jobsUrl&quot;:&quot;https://bookface.ycombinator.com/workatastartup&quot;,&quot;newsItems&quot;:[{&quot;title&quot;:&quot;Granza Bio grabs $7M seed from Felicis and YC to advance delivery of cancer treatments | TechCrunch&quot;,&quot;url&quot;:&quot;https://techcrunch.com/2024/07/03/granza-bio-grabs-7m-seed-from-felicis-and-yc-to-advance-delivery-of-cancer-treatments/&quot;,&quot;date&quot;:&quot;Jul 03, 2024&quot;}],&quot;newsUrl&quot;:&quot;https://bookface.ycombinator.com/company/29485/company_news&quot;,&quot;launches&quot;:[{&quot;id&quot;:78838,&quot;title&quot;:&quot;ðŸŽ¯ðŸ¦   Granza Bio â€“ Cancer targeting attack particles derived from our bodyâ€™s immune system&quot;,&quot;body&quot;:&quot;**Tl;dr:** We are [Granza Bio](https://www.linkedin.com/company/granza-bio-yc-w24/), two PhD graduates in Oncology and Immunology from the University of Oxford on a mission to develop personalised and targeted cancer treatments. We are working on a new weapon in our immune systemâ€™s arsenal â€“ â€œ[**attack particles**](https://www.science.org/doi/10.1126/science.aay9207)â€. We are turning this concept into a therapeutic product that can eliminate any cancer without harming the surrounding healthy cells, preventing adverse side effects.\n\nHey everyone, we are (Ashwin)Â²\n\n![uploaded image](/media/?type=post&amp;id=78838&amp;key=user_uploads/1718918/c608a07f-d480-40c7-bb19-16fc620b9666)\n\n# **Team**\n\nðŸ§‘ðŸ¾[Ashwin Jainarayanan](https://www.linkedin.com/in/jainarayananak/) â€“ Clarendon Scholar and Synthetic Immunologist with extensive research experience on attack particles derived from immune cells.\n\nÂ ðŸ§‘ðŸ¾[Ashwin Nandakumar](https://www.linkedin.com/in/ashwin-nandakumar-menon/) â€“ Cancer biologist specializing in immuno-oncology, who has previously set up clinical trials and brings extensive Oncology start-up experience.\n\nðŸ‘¨ðŸ»â€ðŸ”¬ [Mike Dustin](https://www.kennedy.ox.ac.uk/team/michael-dustin) â€“ Professor of Molecular Immunology at the University of Oxford. Widely recognised for his work on immunological synapses and discovered attack particles.\n\n# **âŒ Problem:**\n\n\\~50% of cancer patients receive treatments that are (1) ineffective and (2) lead to unwanted and avoidable side effects.\n\n**(1) _High mortality rates:_** Ineffective treatments lead to cancer relapse and ultimately, increased likelihood of dying from cancer. Five-year survival rates are lower than 5% for patients with late-stage cancers including lung, pancreas, and brain cancer.\n\n**(2) _Toxicity and adverse side effects_**: While emerging treatments such as immunotherapy and CAR-T cell therapy are effective in some patients, they also impact their healthy tissues. This causes high toxicity and adverse side effects.\n\n# **âœ… Solution: Granza Bioâ€™s cancer-targeting attack particles**\n\nWe have identified **attack particles** âš¡: a powerful suite of weapons in our immune systemâ€™s arsenal. These attack particles carry proteins like **_granzymes_** and **_perforins_** that instantly kill cancer cells.\n\n[Watch how it works!](https://www.youtube.com/watch?v=f5IPz1YaAiE&amp;ab_channel=AshwinMenon)\n\n# **ðŸ“‹ Factfile: Granza Bioâ€™s attack particles**\n\n* **ðŸ’€ High cancer-killing efficacy** in brain, ovarian, lung, and skin cancers.\n* âš™ Engineered to target **only the cancer cells**, leaving the surrounding healthy cells untouched, meaning no toxicity or adverse side effects.\n* ðŸ§  Capable of targeting **brain cancers** by crossing the blood-brain barrier.\n* **ðŸŽ¯** Perfectly suited to a **platform approach** meaning we can use attack particles to target a great range of diseases including cancers, autoimmune diseases, and infections.\n* ðŸ­ **Highly stable** and easy to manufacture.\n\n**Lock &amp; Key method â€“ attack particle targeting cancer**\n\n# \n\n![uploaded image](/media/?type=post&amp;id=78838&amp;key=user_uploads/1718918/0fcc26f3-2645-4d78-aee9-8287c2e707c2)\n\n# **ðŸ™ Our Asks:**\n\n* Share this post with your network and help spread the word!\n* If youâ€™re as excited as we are about this novel approach to eradicating cancer and would like to learn more about what weâ€™re doing, email us at [founders@granzabio.com](mailto:founders@granzabio.com)&quot;,&quot;tagline&quot;:&quot;We engineer \&quot;attack particles\&quot; that selectively target and kill cancer cells, eliminating unwanted side effects and toxicity.&quot;,&quot;created_at&quot;:&quot;2024-02-28T01:19:33.419Z&quot;,&quot;company&quot;:{&quot;id&quot;:29485,&quot;name&quot;:&quot;Granza Bio&quot;,&quot;logo&quot;:&quot;https://bookface-images.s3.amazonaws.com/small_logos/d4fd3a0da81bcc20531e81fb90c199f5f31bc368.png&quot;,&quot;batch&quot;:&quot;w2024&quot;,&quot;tags&quot;:[&quot;Synthetic Biology&quot;,&quot;Biotech&quot;,&quot;Healthcare&quot;,&quot;Therapeutics&quot;,&quot;Oncology&quot;],&quot;url&quot;:&quot;https://www.granzabio.com/&quot;,&quot;slug&quot;:&quot;granza-bio&quot;,&quot;description&quot;:&quot;Cancer targeting attack particles&quot;},&quot;user&quot;:{&quot;name&quot;:&quot;Ashwin Nandakumar&quot;,&quot;avatar&quot;:&quot;https://bookface-images.s3.amazonaws.com/avatars/abf1515406e6713ee0ab505431bf72dd815baad6.jpg&quot;},&quot;total_vote_count&quot;:760,&quot;slug&quot;:&quot;KVa-granza-bio-cancer-targeting-attack-particles-derived-from-our-body-s-immune-system&quot;,&quot;launch_embed_url&quot;:&quot;https://www.ycombinator.com/launches/KVa-granza-bio-cancer-targeting-attack-particles-derived-from-our-body-s-immune-system/upvote_embed.svg&quot;,&quot;twitter_share_url&quot;:&quot;https://twitter.com/intent/tweet?text=Granza+Bio+just+launched+on+%40ycombinator%27s+Launch+YC%21%0A%0A%F0%9F%8E%AF%F0%9F%A6%A0++Granza+Bio+%E2%80%93+Cancer+targeting+attack+particles+derived+from+our+body%E2%80%99s+immune+system.+Check+them+out%3A&amp;url=https%3A%2F%2Fwww.ycombinator.com%2Flaunches%2FKVa-granza-bio-cancer-targeting-attack-particles-derived-from-our-body-s-immune-system&quot;,&quot;sanitized_title&quot;:&quot;ðŸŽ¯ðŸ¦   Granza Bio â€“ Cancer targeting attack particles derived from our bodyâ€™s immune system&quot;,&quot;ycdc_launch_url&quot;:&quot;https://www.ycombinator.com/launches/KVa-granza-bio-cancer-targeting-attack-particles-derived-from-our-body-s-immune-system&quot;,&quot;url&quot;:&quot;https://www.ycombinator.com/launches/KVa-granza-bio-cancer-targeting-attack-particles-derived-from-our-body-s-immune-system&quot;,&quot;share_config&quot;:&quot;{}&quot;,&quot;share_image&quot;:null}],&quot;editUrl&quot;:&quot;https://bookface.ycombinator.com/company/29485/edit&quot;,&quot;editUserUrl&quot;:&quot;https://bookface.ycombinator.com/edit_user_profile&quot;,&quot;createProfileUrl&quot;:&quot;https://account.ycombinator.com/authenticate?continue=https%3A%2F%2Fwww.workatastartup.com%2Fapplication&amp;defaults%5BsignUpActive%5D=true&quot;,&quot;signedIn&quot;:false,&quot;showDirectApply&quot;:true,&quot;waasDirectoryUrl&quot;:&quot;https://www.workatastartup.com/companies&quot;,&quot;investorSubdomain&quot;:false,&quot;userCanRequestEmails&quot;:false},&quot;url&quot;:&quot;/companies/granza-bio&quot;,&quot;version&quot;:null,&quot;rails_context&quot;:{&quot;railsEnv&quot;:&quot;production&quot;,&quot;inMailer&quot;:false,&quot;i18nLocale&quot;:&quot;en&quot;,&quot;i18nDefaultLocale&quot;:&quot;en&quot;,&quot;href&quot;:&quot;https://www.ycombinator.com/companies/granza-bio&quot;,&quot;location&quot;:&quot;/companies/granza-bio&quot;,&quot;scheme&quot;:&quot;https&quot;,&quot;host&quot;:&quot;www.ycombinator.com&quot;,&quot;port&quot;:null,&quot;pathname&quot;:&quot;/companies/granza-bio&quot;,&quot;search&quot;:null,&quot;httpAcceptLanguage&quot;:null,&quot;applyBatchLong&quot;:&quot;Fall 2024&quot;,&quot;applyBatchShort&quot;:&quot;F2024&quot;,&quot;applyDeadlineShort&quot;:&quot;August 27&quot;,&quot;ycdcRetroMode&quot;:true,&quot;currentUser&quot;:null,&quot;serverSide&quot;:true},&quot;id&quot;:&quot;ycdc_new/pages/Companies/ShowPage-react-component-f90b9472-a670-467c-971e-cffb7ca4cb91&quot;,&quot;server_side&quot;:true}" data-reactroot=""><div class="no-scroll-behind relative isolate z-10"><div data-headlessui-state=""><header class="relative mx-auto leading-tight max-w-ycdc-page"><nav class="flex flex-row items-start border-retro-sectionBorder py-[10px] sm:flex-row sm:items-center sm:border-b sm:py-[20px]"><div class="flex w-full flex-1 items-start"><div class="mr-[26px] leading-none"><a class="inline-block h-[56px] w-[56px]" href="/" title="Y Combinator"><img src="data:image/png;base64,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" class="h-full w-full" alt="Y Combinator" width="56" height="56"/></a></div><div class="ml-[30px] hidden flex-1 sm:ml-0 sm:block sm:h-[40px] sm:pt-[18px]"><div class="relative mb-1 mr-4 inline-block"><a href="/about" target="" class="text-[#222] hover:text-linkColor cursor-pointer">About</a><div class="absolute top-[97%] hidden"><div class="mt-2 rounded-lg bg-white shadow-lg focus:outline-none"><div class="flex w-max flex-col px-1 py-1 text-gray-800"><a class="px-4 py-2 hover:bg-gray-200" href="/about" target="">What Happens at YC?</a><a class="px-4 py-2 hover:bg-gray-200" href="/apply" target="">Apply</a><a class="px-4 py-2 hover:bg-gray-200" href="/interviews" target="">YC Interview Guide</a><a class="px-4 py-2 hover:bg-gray-200" href="/faq" target="">FAQ</a><a class="px-4 py-2 hover:bg-gray-200" href="/people" target="">People</a><a class="px-4 py-2 hover:bg-gray-200" href="/blog" target="">YC Blog</a></div></div></div></div><div class="relative mb-1 mr-4 inline-block"><a href="/companies" target="" class="text-[#222] hover:text-linkColor cursor-pointer">Companies</a><div class="absolute top-[97%] hidden"><div class="mt-2 rounded-lg bg-white shadow-lg focus:outline-none"><div class="flex w-max flex-col px-1 py-1 text-gray-800"><a class="px-4 py-2 hover:bg-gray-200" href="/companies" target="">Startup Directory</a><a class="px-4 py-2 hover:bg-gray-200" href="/topcompanies/revenue" target="">Top Companies</a><a class="px-4 py-2 hover:bg-gray-200" href="/companies/founders" target="">Founder Directory</a><a class="px-4 py-2 hover:bg-gray-200" href="/launches" target="">Launch YC</a></div></div></div></div><div class="relative mb-1 mr-4 inline-block"><a href="/jobs" target="" class="text-[#222] hover:text-linkColor cursor-pointer">Startup Jobs</a><div class="absolute top-[97%] hidden"><div class="mt-2 rounded-lg bg-white shadow-lg focus:outline-none"><div class="flex w-max flex-col px-1 py-1 text-gray-800"><a class="px-4 py-2 hover:bg-gray-200" href="/jobs" target="">All Jobs</a><a class="px-4 py-2 hover:bg-gray-200" href="/jobs/role/software-engineer" target="">â—¦ Engineering</a><a class="px-4 py-2 hover:bg-gray-200" href="/jobs/role/operations" target="">â—¦ Operations</a><a class="px-4 py-2 hover:bg-gray-200" href="/jobs/role/marketing" target="">â—¦ Marketing</a><a class="px-4 py-2 hover:bg-gray-200" href="/jobs/role/sales" target="">â—¦ Sales</a><a class="px-4 py-2 hover:bg-gray-200" href="/pioneer-internship-program" target="">Pioneer Internship Program 2024</a><a class="px-4 py-2 hover:bg-gray-200" href="/startup-job-guide" target="">Startup Job Guide</a><a class="px-4 py-2 hover:bg-gray-200" href="/career-coaching" target="">Career Coaching</a><a class="px-4 py-2 hover:bg-gray-200" href="/blog/jobs" target="">YC Startup Jobs Blog</a></div></div></div></div><div class="relative mb-1 mr-4 inline-block"><a href="/cofounder-matching" target="" class="text-[#222] hover:text-linkColor cursor-pointer">Find a Co-Founder</a><div class="absolute top-[97%] hidden"><div class="mt-2 rounded-lg bg-white shadow-lg focus:outline-none"><div class="flex w-max flex-col px-1 py-1 text-gray-800"></div></div></div></div><div class="relative mb-1 mr-4 inline-block"><a href="/library" target="" class="text-[#222] hover:text-linkColor cursor-pointer">Library</a><div class="absolute top-[97%] hidden"><div class="mt-2 rounded-lg bg-white shadow-lg focus:outline-none"><div class="flex w-max flex-col px-1 py-1 text-gray-800"></div></div></div></div><div class="relative mb-1 mr-4 inline-block"><a href="/documents" target="" class="text-[#222] hover:text-linkColor cursor-pointer">SAFE</a><div class="absolute top-[97%] hidden"><div class="mt-2 rounded-lg bg-white shadow-lg focus:outline-none"><div class="flex w-max flex-col px-1 py-1 text-gray-800"></div></div></div></div><div class="relative mb-1 mr-4 inline-block"><a href="/library" target="" class="text-[#222] hover:text-linkColor cursor-pointer">Resources</a><div class="absolute top-[97%] hidden"><div class="mt-2 rounded-lg bg-white shadow-lg focus:outline-none"><div class="flex w-max flex-col px-1 py-1 text-gray-800"><a class="px-4 py-2 hover:bg-gray-200" href="https://startupschool.org?utm_source=yc&amp;utm_campaign=ycdc_header" target="">Startup School</a><a class="px-4 py-2 hover:bg-gray-200" href="/subscribe" target="">Newsletter</a><a class="px-4 py-2 hover:bg-gray-200" href="/investors" target="">For Investors</a><a class="px-4 py-2 hover:bg-gray-200" href="https://news.ycombinator.com/" target="_target">Hacker News</a><a class="px-4 py-2 hover:bg-gray-200" href="https://bookface.ycombinator.com" target="_target">Bookface</a></div></div></div></div></div></div><div><div class="flex items-center sm:hidden"><button class="inline-flex items-center justify-center bg-white p-2 text-gray-400 hover:bg-gray-100 hover:text-gray-500 focus:outline-none focus:ring-2 focus:ring-inset focus:ring-brand-500" type="button" aria-expanded="false" data-headlessui-state=""><span class="sr-only">Open main menu</span><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="2" stroke="currentColor" aria-hidden="true" class="h-6 w-6" width="1.25em" height="1.25em"><path stroke-linecap="round" stroke-linejoin="round" d="M4 6h16M4 12h16M4 18h16"></path></svg></button></div><div class="ml-auto hidden pt-[30px] text-right sm:block sm:h-[60px] sm:pt-[20px]"><span class="inline-block align-middle sm:hidden ycdcMd:hidden ycdcPlus:inline-block">Apply for <b title="Fall 2024 Batch">F2024</b> batch.</span><a class="apply-btn ycdc-retro-btn ml-[13px] mt-[-10px] bg-brand hover:bg-[#ee5d19]" href="/apply" title="Apply for F2024 batch.">Apply</a></div></div></nav></header></div><div style="position:fixed;top:1px;left:1px;width:1px;height:0;padding:0;margin:-1px;overflow:hidden;clip:rect(0, 0, 0, 0);white-space:nowrap;border-width:0;display:none"></div></div><div class="mx-auto max-w-ycdc-page"><section class="relative isolate z-0 border-retro-sectionBorder sm:pr-[13px] ycdcPlus:pr-0 pt-2 sm:pt-4 lg:pt-6 pb-2 sm:pb-4 lg:pb-6"><div class="shared-breadcrumb"><div><a class="shared-breadcrumb-text" href="/">Home</a><span class="shared-breadcrumb-pipe">â€º</span></div><div><a class="shared-breadcrumb-text" href="/companies">Companies</a><span class="shared-breadcrumb-pipe">â€º</span></div><div><span class="shared-breadcrumb-text">Granza Bio</span></div></div><div class="flex flex-col gap-8 sm:flex-row"><div class="flex-grow"><div class="mb-5 flex flex-row items-center gap-x-5"><div class="h-32 w-32 shrink-0 clip-circle-32"><img class="h-full w-full" src="https://bookface-images.s3.amazonaws.com/small_logos/d4fd3a0da81bcc20531e81fb90c199f5f31bc368.png" alt=""/></div><div class="space-y-3"><div class="prose max-w-full"><h1 class="font-extralight">Granza Bio</h1></div><div class="prose hidden max-w-full font-extralight md:block"><div class="text-xl">Cancer targeting attack particles</div></div><div class="align-center flex flex-row flex-wrap gap-x-2 gap-y-2"><a target="_blank" href="/companies?batch=W24"><div class="yc-tw-Pill rounded-sm bg-[#E6E4DC] uppercase tracking-widest px-3 py-[3px] text-[12px] font-thin undefined flex flex-row items-center [&amp;_svg]:text-[#E36D34]"><div class="flex flex-row items-center gap-[6px]"><svg viewBox="0 0 320 320" xmlns="http://www.w3.org/2000/svg" class="inline-block h-3 w-3" width="1.25em" height="1.25em"><title>Y Combinator Logo</title><g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"><g><polygon fill="#F05F22" points="0 320 320 320 320 0 0 0"></polygon><polygon fill="#FFFFFF" points="173 175.8652 173 247.0002 146 247.0002 146 175.8652 77.086 73.0002 110 73.0002 159.628 148.9972 209 73.0002 241.914 73.0002"></polygon></g></g></svg><span>W24</span></div></div></a><div class="yc-tw-Pill rounded-sm bg-[#E6E4DC] uppercase tracking-widest px-3 py-[3px] text-[12px] font-thin"><div class="flex flex-row items-center justify-between"><div class="mr-[6px] h-3 w-3 rounded-full bg-green-500"></div>Active</div></div><a href="/companies/industry/synthetic-biology"><div class="yc-tw-Pill rounded-sm bg-[#E6E4DC] uppercase tracking-widest px-3 py-[3px] text-[12px] font-thin">synthetic-biology</div></a><a href="/companies/industry/biotech"><div class="yc-tw-Pill rounded-sm bg-[#E6E4DC] uppercase tracking-widest px-3 py-[3px] text-[12px] font-thin">biotech</div></a><a href="/companies/industry/healthcare"><div class="yc-tw-Pill rounded-sm bg-[#E6E4DC] uppercase tracking-widest px-3 py-[3px] text-[12px] font-thin">healthcare</div></a><a href="/companies/industry/therapeutics"><div class="yc-tw-Pill rounded-sm bg-[#E6E4DC] uppercase tracking-widest px-3 py-[3px] text-[12px] font-thin">therapeutics</div></a><a href="/companies/industry/oncology"><div class="yc-tw-Pill rounded-sm bg-[#E6E4DC] uppercase tracking-widest px-3 py-[3px] text-[12px] font-thin">oncology</div></a><a href="/companies/location/san-francisco-bay-area"><div class="yc-tw-Pill rounded-sm bg-[#E6E4DC] uppercase tracking-widest px-3 py-[3px] text-[12px] font-thin">San Francisco</div></a></div></div></div><div class="my-8 mb-4"><hr/><div class="flex flex-col justify-between md:flex-row"><nav class="flex justify-start space-x-8"><div class="flex h-16 items-center"><a href="/companies/granza-bio" class="rounded-lg px-3 py-2 text-slate-700 no-underline hover:bg-slate-100 hover:text-slate-900 font-bold">Company</a></div><div class="flex h-16 items-center"><a href="/companies/granza-bio/jobs" class="rounded-lg px-3 py-2 text-slate-700 no-underline hover:bg-slate-100 hover:text-slate-900 ">Jobs</a><span class="ycdc-badge ml-0 font-bold no-underline">0</span></div><div class="flex h-16 items-center"><a href="/companies/granza-bio#news" class="rounded-lg px-3 py-2 text-slate-700 no-underline hover:bg-slate-100 hover:text-slate-900 ">News</a></div></nav><div class="group flex flex-row items-center px-3 leading-none text-linkColor "><a href="https://www.granzabio.com/" target="_blank" class="mb-2 whitespace-nowrap md:mb-0"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="2" stroke="currentColor" aria-hidden="true" width="1.25em" height="1.25em" class="-mt-px inline-block h-4 w-4 group-hover:underline"><path stroke-linecap="round" stroke-linejoin="round" d="M10 6H6a2 2 0 00-2 2v10a2 2 0 002 2h10a2 2 0 002-2v-4M14 4h6m0 0v6m0-6L10 14"></path></svg>Â <div class="inline-block group-hover:underline">https://www.granzabio.com/</div></a></div></div><hr/></div><section class="relative isolate z-0 border-retro-sectionBorder sm:pr-[13px] ycdcPlus:pr-0 pt-1 sm:pt-2 lg:pt-3 pb-1 sm:pb-2 lg:pb-3"><div class="prose max-w-full"><h3 class="sm:block md:hidden">Cancer targeting attack particles</h3><p class="whitespace-pre-line">Granza Bio is developing cancer therapeutics modelled from our bodyâ€™s own immune system. Our therapeutics termed â€œattack particlesâ€ are engineered to specifically target only cancer cells, preventing any unwanted toxicity and adverse side effects. 

Our attack particles have shown cancer-killing efficacy in brain (glioblastoma), ovarian, lung, and skin cancers. Our platform can also be deployed to target a great range of diseases including autoimmune diseases and infections.

Interested to know more? Get in touch founders@granzabio.com!</p></div></section><section class="relative isolate z-0 border-retro-sectionBorder sm:pr-[13px] ycdcPlus:pr-0 pt-1 sm:pt-2 lg:pt-3 pb-1 sm:pb-2 lg:pb-3"><div id="news"><div class="prose mb-4"><h3>Latest News</h3></div><div><div><div class="ycdc-with-link-color mb-1 pr-4 leading-none"><a href="https://techcrunch.com/2024/07/03/granza-bio-grabs-7m-seed-from-felicis-and-yc-to-advance-delivery-of-cancer-treatments/" class="prose font-medium" target="_blank">Granza Bio grabs $7M seed from Felicis and YC to advance delivery of cancer treatments | TechCrunch</a></div><div class="mb-4 text-sm">Jul 03, 2024</div></div></div></div></section></div><div><div class="ycdc-card space-y-1.5 sm:w-[300px]"><img src="https://bookface-images.s3.us-west-2.amazonaws.com/logos/5af6ba4d65c73cf6cdec05dbb069495ee36ae773.png?X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Credential=ASIAQC4NIECAOAZF5OPK%2F20240909%2Fus-west-2%2Fs3%2Faws4_request&amp;X-Amz-Date=20240909T063033Z&amp;X-Amz-Expires=3600&amp;X-Amz-Security-Token=IQoJb3JpZ2luX2VjEC4aCXVzLXdlc3QtMiJIMEYCIQC6PMB8F3tLhC1LgZi%2B%2BuOeMuT8xWaJocDVQsTVm4LDxwIhAKM7Yx2PZ5DVAO3UNlOv2lHhUDcbGWhd4soaoYdDcJLiKuUDCFcQABoMMDA2MjAxODExMDcyIgx%2BCbdALY3WKo2lEB4qwgN4r22%2B9P0f%2B2yravipsTqEUG%2FczMWdPaqQ5MFdNDA32rLIipLzoMJiRRUoj%2Bdfl4Zn5vB8W8WQLEvgQ%2BC2JS4%2FrneWy6SMdzaRspsy2RkqPY07knKxt6Ro9mX%2BAZDaX%2BCLuAWF5Ptdg6ySpHhcaBVUepAgFHD8Y5l8TOfix6ccA2nI%2BwaCT8eQd%2FvFBAYzYOHxz2T%2FBtrLM3vTIjIQpXhVA4wLkni%2F6JWKrtrgfKy1C0LU7%2FsOwyeTEHLgx%2F9iHZStsmzCacSDuuJ2VBpFzXIn%2BPgl1G%2FL3SwcOdVXRyU08TmpA4hs7om9GQ2zBpl2uIywqLr8Ns7vSm7ZU%2Fwyf237mDK4ELpXhpMcatweNujmgzUvuWS%2BTGESofv2EUXa6m5FvWNmgrW0dCgp6ibDuf%2Bs9SSc54k3%2BtYP710eskdjXZcgPG2joKfh3ruh8%2F7q7b%2Fk0ydfg%2FHlMG8kJ9zSPJ41HUP3%2FFRD1g715zSBXY9dQkvpT4oCjBNFlOxtkSpHdqhVJoTXwCjbltXuFhuri7V13CRzbS7ECUhTUY1%2B4FvSItFiH3BMIXarTh3N2LYmtTXJoRbInPJvNv%2Fv49sCcaZ3XxIwhpr6tgY6pAFaSnEZEhA%2FGoDn9kaSASqz%2FQjgwNLJzXfnuyR%2BwZzJHYeiYLQ9GIIEvSx84TlHHMkq3XbUgorF8009Pcr7hjT0qn14qSv%2FxSVb6%2FJA0WaxQF1rwSffJbqa8o7rH49tbvJyaapr8TTGmAlJL8Iexk3VmxxxBYaUmsJjUGunQmgonDUKV9X38d1tBQH%2Bf9GZclUO9nu0rka1V9UYLRMOBB1nD43ilA%3D%3D&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Signature=cfa41885082723861dcb4a6719ee0d54113e1730c49d82f609150989cce839d5" class="hidden max-w-[200px] sm:block" alt="Granza Bio"/><div class="text-lg font-bold">Granza Bio</div><div class="space-y-0.5"><div class="flex flex-row justify-between"><span>Founded:</span><span>2023</span></div><div class="flex flex-row justify-between"><span>Team Size:</span><span>2</span></div><div class="flex flex-row justify-between"><span>Location:</span><span>San Francisco</span></div><div class="flex flex-row justify-between"><span>Group Partner:</span><a href="https://www.ycombinator.com/people/surbhi-sarna" class="text-linkColor">Surbhi Sarna</a></div></div><div class="space-x-2"><a href="https://www.linkedin.com/company/101140973/" class="inline-block w-5 h-5 bg-contain bg-image-linkedin" title="LinkedIn profile" aria-label="LinkedIn profile" rel="nofollow">Â </a><a href="https://twitter.com/GranzaBio" class="inline-block w-5 h-5 bg-contain bg-image-twitter" title="Twitter account" aria-label="Twitter account" rel="nofollow">Â </a></div></div></div></div></section><div><section class="relative isolate z-0 border-retro-sectionBorder sm:pr-[13px] ycdcPlus:pr-0 pt-1 sm:pt-2 lg:pt-3 pb-1 sm:pb-2 lg:pb-3"><div class="prose mb-4"><h3>Active Founders</h3></div><div class="space-y-5"><div class="flex flex-row flex-col items-start gap-3 md:flex-row"><div class="flex-grow"><h3 class="text-lg font-bold">Ashwin Nandakumar</h3><p class="prose max-w-full whitespace-pre-line">Ashwin completed his PhD (DPhil) in Oncology at the University of Oxford. After completing his PhD, he began working as a Cancer Research UK post-doctoral researcher at Oxford University and also at the Institute of Cancer Research (ICR), London. He also brings experience setting up oncology clinical trials and working in oncology start-ups. </p></div><div class="shrink-0 space-y-1.5 rounded-md border-[1px] border-[#999] bg-[#FDFDF7] p-6 sm:w-[300px]"><div class="flex flex-row items-center gap-x-3"><img src="https://bookface-images.s3.us-west-2.amazonaws.com/avatars/abf1515406e6713ee0ab505431bf72dd815baad6.jpg?X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Credential=ASIAQC4NIECAOAZF5OPK%2F20240909%2Fus-west-2%2Fs3%2Faws4_request&amp;X-Amz-Date=20240909T063033Z&amp;X-Amz-Expires=3600&amp;X-Amz-Security-Token=IQoJb3JpZ2luX2VjEC4aCXVzLXdlc3QtMiJIMEYCIQC6PMB8F3tLhC1LgZi%2B%2BuOeMuT8xWaJocDVQsTVm4LDxwIhAKM7Yx2PZ5DVAO3UNlOv2lHhUDcbGWhd4soaoYdDcJLiKuUDCFcQABoMMDA2MjAxODExMDcyIgx%2BCbdALY3WKo2lEB4qwgN4r22%2B9P0f%2B2yravipsTqEUG%2FczMWdPaqQ5MFdNDA32rLIipLzoMJiRRUoj%2Bdfl4Zn5vB8W8WQLEvgQ%2BC2JS4%2FrneWy6SMdzaRspsy2RkqPY07knKxt6Ro9mX%2BAZDaX%2BCLuAWF5Ptdg6ySpHhcaBVUepAgFHD8Y5l8TOfix6ccA2nI%2BwaCT8eQd%2FvFBAYzYOHxz2T%2FBtrLM3vTIjIQpXhVA4wLkni%2F6JWKrtrgfKy1C0LU7%2FsOwyeTEHLgx%2F9iHZStsmzCacSDuuJ2VBpFzXIn%2BPgl1G%2FL3SwcOdVXRyU08TmpA4hs7om9GQ2zBpl2uIywqLr8Ns7vSm7ZU%2Fwyf237mDK4ELpXhpMcatweNujmgzUvuWS%2BTGESofv2EUXa6m5FvWNmgrW0dCgp6ibDuf%2Bs9SSc54k3%2BtYP710eskdjXZcgPG2joKfh3ruh8%2F7q7b%2Fk0ydfg%2FHlMG8kJ9zSPJ41HUP3%2FFRD1g715zSBXY9dQkvpT4oCjBNFlOxtkSpHdqhVJoTXwCjbltXuFhuri7V13CRzbS7ECUhTUY1%2B4FvSItFiH3BMIXarTh3N2LYmtTXJoRbInPJvNv%2Fv49sCcaZ3XxIwhpr6tgY6pAFaSnEZEhA%2FGoDn9kaSASqz%2FQjgwNLJzXfnuyR%2BwZzJHYeiYLQ9GIIEvSx84TlHHMkq3XbUgorF8009Pcr7hjT0qn14qSv%2FxSVb6%2FJA0WaxQF1rwSffJbqa8o7rH49tbvJyaapr8TTGmAlJL8Iexk3VmxxxBYaUmsJjUGunQmgonDUKV9X38d1tBQH%2Bf9GZclUO9nu0rka1V9UYLRMOBB1nD43ilA%3D%3D&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Signature=f3a43e9142adfc8820edf5aa7ae76172e1b832e12c8327df06a63f0743b336da" width="75" height="75" class="h-[75px] w-[75px] object-cover" alt="Ashwin Nandakumar"/><div class="leading-snug"><div class="font-bold">Ashwin Nandakumar</div><a class="block text-linkColor" href="/companies/granza-bio">Granza Bio</a><div class="mt-1 space-x-2"><a href="https://twitter.com/Menon_Ashwin" class="inline-block h-5 w-5 bg-contain bg-image-twitter" title="Twitter account" aria-label="Twitter account" rel="nofollow">Â </a><a href="https://linkedin.com/in/ashwin-nandakumar-menon" class="inline-block h-5 w-5 bg-contain bg-image-linkedin" title="LinkedIn profile" aria-label="LinkedIn profile" rel="nofollow">Â </a></div></div></div></div></div><div class="flex flex-row flex-col items-start gap-3 md:flex-row"><div class="flex-grow"><h3 class="text-lg font-bold">Ashwin Jainarayanan</h3><p class="prose max-w-full whitespace-pre-line">Granza Bio, DPhil (PhD) in Interdisciplinary Bioscience - University of Oxford

</p></div><div class="shrink-0 space-y-1.5 rounded-md border-[1px] border-[#999] bg-[#FDFDF7] p-6 sm:w-[300px]"><div class="flex flex-row items-center gap-x-3"><img src="https://bookface-images.s3.us-west-2.amazonaws.com/avatars/d8cf072b7b583aa501ae03f0113abf686b2e0b73.jpg?X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Credential=ASIAQC4NIECAOAZF5OPK%2F20240909%2Fus-west-2%2Fs3%2Faws4_request&amp;X-Amz-Date=20240909T063033Z&amp;X-Amz-Expires=3600&amp;X-Amz-Security-Token=IQoJb3JpZ2luX2VjEC4aCXVzLXdlc3QtMiJIMEYCIQC6PMB8F3tLhC1LgZi%2B%2BuOeMuT8xWaJocDVQsTVm4LDxwIhAKM7Yx2PZ5DVAO3UNlOv2lHhUDcbGWhd4soaoYdDcJLiKuUDCFcQABoMMDA2MjAxODExMDcyIgx%2BCbdALY3WKo2lEB4qwgN4r22%2B9P0f%2B2yravipsTqEUG%2FczMWdPaqQ5MFdNDA32rLIipLzoMJiRRUoj%2Bdfl4Zn5vB8W8WQLEvgQ%2BC2JS4%2FrneWy6SMdzaRspsy2RkqPY07knKxt6Ro9mX%2BAZDaX%2BCLuAWF5Ptdg6ySpHhcaBVUepAgFHD8Y5l8TOfix6ccA2nI%2BwaCT8eQd%2FvFBAYzYOHxz2T%2FBtrLM3vTIjIQpXhVA4wLkni%2F6JWKrtrgfKy1C0LU7%2FsOwyeTEHLgx%2F9iHZStsmzCacSDuuJ2VBpFzXIn%2BPgl1G%2FL3SwcOdVXRyU08TmpA4hs7om9GQ2zBpl2uIywqLr8Ns7vSm7ZU%2Fwyf237mDK4ELpXhpMcatweNujmgzUvuWS%2BTGESofv2EUXa6m5FvWNmgrW0dCgp6ibDuf%2Bs9SSc54k3%2BtYP710eskdjXZcgPG2joKfh3ruh8%2F7q7b%2Fk0ydfg%2FHlMG8kJ9zSPJ41HUP3%2FFRD1g715zSBXY9dQkvpT4oCjBNFlOxtkSpHdqhVJoTXwCjbltXuFhuri7V13CRzbS7ECUhTUY1%2B4FvSItFiH3BMIXarTh3N2LYmtTXJoRbInPJvNv%2Fv49sCcaZ3XxIwhpr6tgY6pAFaSnEZEhA%2FGoDn9kaSASqz%2FQjgwNLJzXfnuyR%2BwZzJHYeiYLQ9GIIEvSx84TlHHMkq3XbUgorF8009Pcr7hjT0qn14qSv%2FxSVb6%2FJA0WaxQF1rwSffJbqa8o7rH49tbvJyaapr8TTGmAlJL8Iexk3VmxxxBYaUmsJjUGunQmgonDUKV9X38d1tBQH%2Bf9GZclUO9nu0rka1V9UYLRMOBB1nD43ilA%3D%3D&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Signature=29b24a3a37f185d61e2232b2a88439dad0bbbbc0749fa32653802a4a19c73f31" width="75" height="75" class="h-[75px] w-[75px] object-cover" alt="Ashwin Jainarayanan"/><div class="leading-snug"><div class="font-bold">Ashwin Jainarayanan</div><a class="block text-linkColor" href="/companies/granza-bio">Granza Bio</a><div class="mt-1 space-x-2"><a href="https://linkedin.com/in/jainarayananak" class="inline-block h-5 w-5 bg-contain bg-image-linkedin" title="LinkedIn profile" aria-label="LinkedIn profile" rel="nofollow">Â </a></div></div></div></div></div></div></section></div><section class="relative isolate z-0 border-retro-sectionBorder sm:pr-[13px] ycdcPlus:pr-0 pt-1 sm:pt-2 lg:pt-3 pb-1 sm:pb-2 lg:pb-3"><div class="prose mb-4"><h3>Company Launches</h3></div><div><div class="prose max-w-full prose-h2:mt-0"><a href="/launches/KVa-granza-bio-cancer-targeting-attack-particles-derived-from-our-body-s-immune-system" class="ycdc-with-link-color mb-4 mt-0 text-xl underline"><h3>ðŸŽ¯ðŸ¦   Granza Bio â€“ Cancer targeting attack particles derived from our bodyâ€™s immune system</h3></a></div><div class="prose max-w-full"><div><p><strong>Tl;dr:</strong> We are <a href="https://www.linkedin.com/company/granza-bio-yc-w24/">Granza Bio</a>, two PhD graduates in Oncology and Immunology from the University of Oxford on a mission to develop personalised and targeted cancer treatments. We are working on a new weapon in our immune systemâ€™s arsenal â€“ â€œ<a href="https://www.science.org/doi/10.1126/science.aay9207"><strong>attack particles</strong></a>â€. We are turning this concept into a therapeutic product that can eliminate any cancer without harming the surrounding healthy cells, preventing adverse side effects.</p>
<p>Hey everyone, we are (Ashwin)Â²</p>
<p><img src="/media/?type=post&amp;id=78838&amp;key=user_uploads/1718918/c608a07f-d480-40c7-bb19-16fc620b9666" /></p>
<h1><strong>Team</strong></h1>
<p>ðŸ§‘ðŸ¾<a href="https://www.linkedin.com/in/jainarayananak/">Ashwin Jainarayanan</a> â€“ Clarendon Scholar and Synthetic Immunologist with extensive research experience on attack particles derived from immune cells.</p>
<p>ðŸ§‘ðŸ¾<a href="https://www.linkedin.com/in/ashwin-nandakumar-menon/">Ashwin Nandakumar</a> â€“ Cancer biologist specializing in immuno-oncology, who has previously set up clinical trials and brings extensive Oncology start-up experience.</p>
<p>ðŸ‘¨ðŸ»â€ðŸ”¬ <a href="https://www.kennedy.ox.ac.uk/team/michael-dustin">Mike Dustin</a> â€“ Professor of Molecular Immunology at the University of Oxford. Widely recognised for his work on immunological synapses and discovered attack particles.</p>
<h1><strong>âŒ Problem:</strong></h1>
<p>~50% of cancer patients receive treatments that are (1) ineffective and (2) lead to unwanted and avoidable side effects.</p>
<p><strong>(1) <em>High mortality rates:</em></strong> Ineffective treatments lead to cancer relapse and ultimately, increased likelihood of dying from cancer. Five-year survival rates are lower than 5% for patients with late-stage cancers including lung, pancreas, and brain cancer.</p>
<p><strong>(2) <em>Toxicity and adverse side effects</em></strong>: While emerging treatments such as immunotherapy and CAR-T cell therapy are effective in some patients, they also impact their healthy tissues. This causes high toxicity and adverse side effects.</p>
<h1><strong>âœ… Solution: Granza Bioâ€™s cancer-targeting attack particles</strong></h1>
<p>We have identified <strong>attack particles</strong> âš¡: a powerful suite of weapons in our immune systemâ€™s arsenal. These attack particles carry proteins like <strong><em>granzymes</em></strong> and <strong><em>perforins</em></strong> that instantly kill cancer cells.</p>
<p><a href="https://www.youtube.com/watch?v=f5IPz1YaAiE&amp;ab_channel=AshwinMenon">Watch how it works!</a></p><p class="embed-container youtube">
<iframe width="560" height="315" src="https://www.youtube.com/embed/f5IPz1YaAiE" frameborder="0" allowfullscreen></iframe>
</p><p></p>
<h1><strong>ðŸ“‹ Factfile: Granza Bioâ€™s attack particles</strong></h1>
<ul>
<li><strong>ðŸ’€ High cancer-killing efficacy</strong> in brain, ovarian, lung, and skin cancers.</li>
<li>âš™ Engineered to target <strong>only the cancer cells</strong>, leaving the surrounding healthy cells untouched, meaning no toxicity or adverse side effects.</li>
<li>ðŸ§  Capable of targeting <strong>brain cancers</strong> by crossing the blood-brain barrier.</li>
<li><strong>ðŸŽ¯</strong> Perfectly suited to a <strong>platform approach</strong> meaning we can use attack particles to target a great range of diseases including cancers, autoimmune diseases, and infections.</li>
<li>ðŸ­ <strong>Highly stable</strong> and easy to manufacture.</li>
</ul>
<p><strong>Lock &amp; Key method â€“ attack particle targeting cancer</strong></p>
<h1></h1>
<p><img src="/media/?type=post&amp;id=78838&amp;key=user_uploads/1718918/0fcc26f3-2645-4d78-aee9-8287c2e707c2" /></p>
<h1><strong>ðŸ™ Our Asks:</strong></h1>
<ul>
<li>Share this post with your network and help spread the word!</li>
<li>If youâ€™re as excited as we are about this novel approach to eradicating cancer and would like to learn more about what weâ€™re doing, email us at <a href="mailto:founders@granzabio.com">founders@granzabio.com</a></li>
</ul>
</div></div></div></section><section class="relative isolate z-0 border-retro-sectionBorder sm:pr-[13px] ycdcPlus:pr-0 pt-6 lg:pt-9 pb-6 lg:pb-9"><div class="prose"><h4>YC Sign Photo</h4><img src="https://bookface-images.s3.us-west-2.amazonaws.com/attachments/951f3c1e19296f2e20fadafd3714fde2998a701f.png?X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Credential=ASIAQC4NIECAOAZF5OPK%2F20240909%2Fus-west-2%2Fs3%2Faws4_request&amp;X-Amz-Date=20240909T063033Z&amp;X-Amz-Expires=3600&amp;X-Amz-Security-Token=IQoJb3JpZ2luX2VjEC4aCXVzLXdlc3QtMiJIMEYCIQC6PMB8F3tLhC1LgZi%2B%2BuOeMuT8xWaJocDVQsTVm4LDxwIhAKM7Yx2PZ5DVAO3UNlOv2lHhUDcbGWhd4soaoYdDcJLiKuUDCFcQABoMMDA2MjAxODExMDcyIgx%2BCbdALY3WKo2lEB4qwgN4r22%2B9P0f%2B2yravipsTqEUG%2FczMWdPaqQ5MFdNDA32rLIipLzoMJiRRUoj%2Bdfl4Zn5vB8W8WQLEvgQ%2BC2JS4%2FrneWy6SMdzaRspsy2RkqPY07knKxt6Ro9mX%2BAZDaX%2BCLuAWF5Ptdg6ySpHhcaBVUepAgFHD8Y5l8TOfix6ccA2nI%2BwaCT8eQd%2FvFBAYzYOHxz2T%2FBtrLM3vTIjIQpXhVA4wLkni%2F6JWKrtrgfKy1C0LU7%2FsOwyeTEHLgx%2F9iHZStsmzCacSDuuJ2VBpFzXIn%2BPgl1G%2FL3SwcOdVXRyU08TmpA4hs7om9GQ2zBpl2uIywqLr8Ns7vSm7ZU%2Fwyf237mDK4ELpXhpMcatweNujmgzUvuWS%2BTGESofv2EUXa6m5FvWNmgrW0dCgp6ibDuf%2Bs9SSc54k3%2BtYP710eskdjXZcgPG2joKfh3ruh8%2F7q7b%2Fk0ydfg%2FHlMG8kJ9zSPJ41HUP3%2FFRD1g715zSBXY9dQkvpT4oCjBNFlOxtkSpHdqhVJoTXwCjbltXuFhuri7V13CRzbS7ECUhTUY1%2B4FvSItFiH3BMIXarTh3N2LYmtTXJoRbInPJvNv%2Fv49sCcaZ3XxIwhpr6tgY6pAFaSnEZEhA%2FGoDn9kaSASqz%2FQjgwNLJzXfnuyR%2BwZzJHYeiYLQ9GIIEvSx84TlHHMkq3XbUgorF8009Pcr7hjT0qn14qSv%2FxSVb6%2FJA0WaxQF1rwSffJbqa8o7rH49tbvJyaapr8TTGmAlJL8Iexk3VmxxxBYaUmsJjUGunQmgonDUKV9X38d1tBQH%2Bf9GZclUO9nu0rka1V9UYLRMOBB1nD43ilA%3D%3D&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Signature=a3487f8863ad7ec76bff2a2947e4b74202a249035c9aa7aa44c045904e5a0c01" alt="YC Sign Photo"/></div></section></div><footer aria-labelledby="footer-heading"><h2 id="footer-heading" class="sr-only">Footer</h2><div class="mx-auto max-w-ycdc-page py-12 lg:py-16"><div class="flex flex-col space-y-8 md:flex-row md:space-y-0"><div class="md:pr-16"><a class="block h-[45px] w-[45px] sm:h-[60px] sm:w-[60px]" href="/" title="Y Combinator"><span class="sr-only">Y Combinator</span><img src="data:image/png;base64,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" class="h-full w-full" alt="Y Combinator" width="60" height="60"/></a></div><div class="flex flex-col space-y-8 sm:flex-row sm:space-x-16 sm:space-y-0 md:justify-items-center"><div><h3 class="font-semibold tracking-wider">Programs</h3><ul class="mt-2 space-y-1"><li><a href="/about" class="font-light text-sm text-inherit">YC Program</a></li><li><a href="https://startupschool.org" class="font-light text-sm text-inherit">Startup School</a></li><li><a href="/jobs" class="font-light text-sm text-inherit">Work at a Startup</a></li><li><a href="/cofounder-matching" class="font-light text-sm text-inherit">Co-Founder Matching</a></li></ul></div><div><h3 class="font-semibold tracking-wider">Company</h3><ul class="mt-2 space-y-1"><li><a href="/blog" class="font-light text-sm text-inherit">YC Blog</a></li><li><a href="/contact" class="font-light text-sm text-inherit">Contact</a></li><li><a href="/press" class="font-light text-sm text-inherit">Press</a></li><li><a href="/people" class="font-light text-sm text-inherit">People</a></li><li><a href="/careers" class="font-light text-sm text-inherit">Careers</a></li><li><a href="/legal#privacy" class="font-light text-sm text-inherit">Privacy Policy</a></li><li><a href="/legal#notice-at-collection" class="font-light text-sm text-inherit">Notice at Collection</a></li><li><a href="/security" class="font-light text-sm text-inherit">Security</a></li><li><a href="/legal#tou" class="font-light text-sm text-inherit">Terms of Use</a></li></ul></div><div><h3 class="font-semibold tracking-wider">Resources</h3><ul class="mt-2 space-y-1"><li><a href="/companies" class="font-light text-sm text-inherit">Startup Directory</a></li><li><a href="/library" class="font-light text-sm text-inherit">Startup Library</a></li><li><a href="/investors" class="font-light text-sm text-inherit">Investors</a></li><li><a href="/documents" class="font-light text-sm text-inherit">SAFE</a></li><li><a href="https://news.ycombinator.com/" class="font-light text-sm text-inherit">Hacker News</a></li><li><a href="/launches" class="font-light text-sm text-inherit">Launch YC</a></li><li><a href="https://deals.ycombinator.com" class="font-light text-sm text-inherit">YC Deals</a></li></ul></div></div><div class="mt-8 flex-1 space-x-2 sm:text-right md:mt-0"><h3 class="inline-block text-[1.17em] md:hidden lg:inline-block ycdcPlus:mr-0">Make something people want.</h3><a href="/apply" class="apply-btn ycdc-retro-btn ml-[13px] mt-[-10px] bg-brand hover:bg-[#ee5d19]">Apply</a></div></div><div class="mt-8 border-t border-gray-200 pt-8 md:flex md:items-center md:justify-between"><div class="flex space-x-6 md:order-2"><a href="https://twitter.com/ycombinator" target="_blank" class=""><span class="sr-only">Twitter</span><svg fill="currentColor" viewBox="0 0 24 24" width="1.25em" height="1.25em" class="h-6 w-6" aria-hidden="true"><title>Twitter</title><path d="M8.29 20.251c7.547 0 11.675-6.253 11.675-11.675 0-.178 0-.355-.012-.53A8.348 8.348 0 0022 5.92a8.19 8.19 0 01-2.357.646 4.118 4.118 0 001.804-2.27 8.224 8.224 0 01-2.605.996 4.107 4.107 0 00-6.993 3.743 11.65 11.65 0 01-8.457-4.287 4.106 4.106 0 001.27 5.477A4.072 4.072 0 012.8 9.713v.052a4.105 4.105 0 003.292 4.022 4.095 4.095 0 01-1.853.07 4.108 4.108 0 003.834 2.85A8.233 8.233 0 012 18.407a11.616 11.616 0 006.29 1.84"></path></svg></a><a href="https://www.facebook.com/YCombinator/" target="_blank" class=""><span class="sr-only">Facebook</span><svg fill="currentColor" viewBox="0 0 24 24" width="1.25em" height="1.25em" class="h-6 w-6" aria-hidden="true"><title>Facebook</title><path fill-rule="evenodd" d="M22 12c0-5.523-4.477-10-10-10S2 6.477 2 12c0 4.991 3.657 9.128 8.438 9.878v-6.987h-2.54V12h2.54V9.797c0-2.506 1.492-3.89 3.777-3.89 1.094 0 2.238.195 2.238.195v2.46h-1.26c-1.243 0-1.63.771-1.63 1.562V12h2.773l-.443 2.89h-2.33v6.988C18.343 21.128 22 16.991 22 12z" clip-rule="evenodd"></path></svg></a><a href="https://www.instagram.com/ycombinator" target="_blank" class=""><span class="sr-only">Instagram</span><svg fill="currentColor" viewBox="0 0 24 24" width="1.25em" height="1.25em" class="h-6 w-6" aria-hidden="true"><title>Instagram</title><path fill-rule="evenodd" d="M12.315 2c2.43 0 2.784.013 3.808.06 1.064.049 1.791.218 2.427.465a4.902 4.902 0 011.772 1.153 4.902 4.902 0 011.153 1.772c.247.636.416 1.363.465 2.427.048 1.067.06 1.407.06 4.123v.08c0 2.643-.012 2.987-.06 4.043-.049 1.064-.218 1.791-.465 2.427a4.902 4.902 0 01-1.153 1.772 4.902 4.902 0 01-1.772 1.153c-.636.247-1.363.416-2.427.465-1.067.048-1.407.06-4.123.06h-.08c-2.643 0-2.987-.012-4.043-.06-1.064-.049-1.791-.218-2.427-.465a4.902 4.902 0 01-1.772-1.153 4.902 4.902 0 01-1.153-1.772c-.247-.636-.416-1.363-.465-2.427-.047-1.024-.06-1.379-.06-3.808v-.63c0-2.43.013-2.784.06-3.808.049-1.064.218-1.791.465-2.427a4.902 4.902 0 011.153-1.772A4.902 4.902 0 015.45 2.525c.636-.247 1.363-.416 2.427-.465C8.901 2.013 9.256 2 11.685 2h.63zm-.081 1.802h-.468c-2.456 0-2.784.011-3.807.058-.975.045-1.504.207-1.857.344-.467.182-.8.398-1.15.748-.35.35-.566.683-.748 1.15-.137.353-.3.882-.344 1.857-.047 1.023-.058 1.351-.058 3.807v.468c0 2.456.011 2.784.058 3.807.045.975.207 1.504.344 1.857.182.466.399.8.748 1.15.35.35.683.566 1.15.748.353.137.882.3 1.857.344 1.054.048 1.37.058 4.041.058h.08c2.597 0 2.917-.01 3.96-.058.976-.045 1.505-.207 1.858-.344.466-.182.8-.398 1.15-.748.35-.35.566-.683.748-1.15.137-.353.3-.882.344-1.857.048-1.055.058-1.37.058-4.041v-.08c0-2.597-.01-2.917-.058-3.96-.045-.976-.207-1.505-.344-1.858a3.097 3.097 0 00-.748-1.15 3.098 3.098 0 00-1.15-.748c-.353-.137-.882-.3-1.857-.344-1.023-.047-1.351-.058-3.807-.058zM12 6.865a5.135 5.135 0 110 10.27 5.135 5.135 0 010-10.27zm0 1.802a3.333 3.333 0 100 6.666 3.333 3.333 0 000-6.666zm5.338-3.205a1.2 1.2 0 110 2.4 1.2 1.2 0 010-2.4z" clip-rule="evenodd"></path></svg></a><a href="https://www.linkedin.com/school/y-combinator/" target="_blank" class=""><span class="sr-only">LinkedIn</span><svg fill="currentColor" viewBox="0 0 24 24" width="1.25em" height="1.25em" class="h-6 w-6" aria-hidden="true"><title>LinkedIn</title><path d="M20.447 20.452h-3.554v-5.569c0-1.328-.027-3.037-1.852-3.037-1.853 0-2.136 1.445-2.136 2.939v5.667H9.351V9h3.414v1.561h.046c.477-.9 1.637-1.85 3.37-1.85 3.601 0 4.267 2.37 4.267 5.455v6.286zM5.337 7.433c-1.144 0-2.063-.926-2.063-2.065 0-1.138.92-2.063 2.063-2.063 1.14 0 2.064.925 2.064 2.063 0 1.139-.925 2.065-2.064 2.065zm1.782 13.019H3.555V9h3.564v11.452zM22.225 0H1.771C.792 0 0 .774 0 1.729v20.542C0 23.227.792 24 1.771 24h20.451C23.2 24 24 23.227 24 22.271V1.729C24 .774 23.2 0 22.222 0h.003z"></path></svg></a><a href="https://www.youtube.com/c/ycombinator" target="_blank" class=""><span class="sr-only">Youtube</span><svg fill="currentColor" viewBox="0 0 24 24" width="1.25em" height="1.25em" class="h-6 w-6" aria-hidden="true"><title>YouTube</title><path d="M23.498 6.186a3.016 3.016 0 0 0-2.122-2.136C19.505 3.545 12 3.545 12 3.545s-7.505 0-9.377.505A3.017 3.017 0 0 0 .502 6.186C0 8.07 0 12 0 12s0 3.93.502 5.814a3.016 3.016 0 0 0 2.122 2.136c1.871.505 9.376.505 9.376.505s7.505 0 9.377-.505a3.015 3.015 0 0 0 2.122-2.136C24 15.93 24 12 24 12s0-3.93-.502-5.814zM9.545 15.568V8.432L15.818 12l-6.273 3.568z"></path></svg></a></div><p class="mt-8 text-base md:order-1 md:mt-0">Â© 2024 Y Combinator</p></div></div></footer></div></body></html>